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2010). Part B and E used. ...................................................................................... 204 
Appendix 7: Reactions to Impairment and Disability Inventory (RIDI; Livneh & 
Antonak, 1990). Adjustment subscale used. ........................................................... 205 
Appendix 8: Future Fluency Task (FFT; MacLeod et al., 1997). .......................... 206 
Appendix 10: Client Satisfaction Questionnaire (CSQ; Larsen, Attkisson, 
Hargreaves & Nguyen, 1979). ................................................................................ 210 
Appendix 11: Full therapy protocol. ...................................................................... 211 
Appendix 12: TAU-U analysis for participants VAS data across phases. ............. 229 






























List of Figures and Tables 
List of Figures 
Figure 1: PRISMA Diagram Outlining the Screening and Selection Process ………26 
Figure 2: Overview of Recruitment and Retention …………………………………87 
Figure 3: Key for Central Tendency and Overlap Ranges Indicators used for 
Participants VAS Graphs …………………………………………………………..106 
 
Figure 4: Pt1: Raw VAS Data for Low Mood ……………………………………..108 
 
Figure 5: Pt1: Raw VAS Data for Meaningful Behaviour …………………………109 
Figure 6: Pt2: Raw VAS Data for Low Mood ……………………………………..111 
Figure 7: Pt2: Raw VAS Data for Meaningful Behaviour ………………………....112 
Figure 8: Pt3: Raw VAS Data for Low Mood ……………………………………..115 
Figure 9: Pt3: Raw VAS Data for Meaningful Behaviour ………………………....116 
 
Figure 10: Pt4: Raw VAS Data for Low Mood …………………………………....119 
 
Figure 11: Pt4: Raw VAS Data for Meaningful Behaviour ………………………..120 
Figure 12: Comparison between Pre-intervention and Follow-up HADS-Depression 
Scores (n=4) ………………………………………………………………………...122 
Figure 13: Comparison between Pre-intervention and Follow-up QOLIBRI-Self 
Scores (n=4) ………………………………………………………………………...123 
Figure 14: Comparison between Pre-intervention and Follow-up QOLIBRI-Emotions 
Scores (n=4) ……………………………………………………………...................124 
Figure 15: Comparison between Pre-intervention and Follow-up RIDI-Adjustment 
Scores (n=4) ………………………………………………………………………...125 
 
List of Tables 
Table 1: Search Terms for Electronic Databases .…………………………………..24 
Table 2: Effect Size Classifications ………...………………….……………………..29 
Table 3: Characteristics of Studies Documenting Cognition, Mood, and/or Behaviour 
Related Outcomes after Imagery Interventions in ABI …..…………………………34 
 6 
Table 4: Quality Ratings using the EPHPP tool …………………………………….54 
Table 5: Intervention Integrity and Analysis using EPHPP tool ………...............….55 
Table 6: Kazdin’s (2019) Criterion for Evaluating Change in Visual Analysis ..........95 
 
Table 7: Reliability and Normative Sample Statistics used to Calculate RC and CSC 
………………………………………………………………………………………..97 
 
Table 8: Participant Information …………………………………….…………….101 
Table 9: Values Bullseye Ratings ………………………………..…………………105 
Table 10: Findings from the Future Thinking Task Converted to Positive Bias Scores 
of 0-1 ……………………………………………………………………………….127 
Table 11: CSQ Total Scores Converted to Acceptability Ratings of 0-100 ……….130 
Table 12: TAU-U Analysis for Participants VAS Data Across Phases ….…………228 
 













Chapter I: Lay Summary 
Systematic Review: Is Imagery an Effective Method of Intervening 
Psychologically with Acquired Brain Injury (ABI) Groups? 
 
Background 
An acquired brain injury (ABI) is any damage to the brain that occurs after 
birth. The two main causes of an ABI are a stroke (when a blood vessel in the brain 
bursts or is blocked) and a traumatic brain injury (when sudden trauma causes 
damage to the brain). After an injury, individuals can experience different symptoms 
including physical problems and changes in their thinking, behaviour, and mood. 
Mental imagery refers to mental representations and sensory experiences without a 
direct external stimulus (i.e., asking individuals to imagine something: ‘seeing in 
the mind’s eye’, ‘hearing in the head’, ‘imagining the feel of’ and so on). In individuals 
without an ABI, imagery-based interventions have positively impacted mood and 
thinking skills, and successfully increased motivation across a range of behaviours. 
The aim of this review was to explore the influence of imagery-based approaches on 
psychological outcomes (thinking, mood, or behaviour) in individuals with an ABI. 
Method 
A systematic search of research databases was conducted to find published 
studies that looked at imagery-based interventions for adults (18+) after an ABI. 
Studies were required to examine the effect of imagery on participants thinking skills 
(e.g., memory, attention), mood (e.g., depression, anxiety), and/or behaviour (e.g., 
disinhibited behaviour). Only quantitative studies (those looking at numerical data) 
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were included. Studies had to be written in English and published after 2010. Nine 
studies were included in the review and the quality of each study was evaluated. 
Results 
The exact use of imagery varied across studies. Seven studies primarily explored 
the effect of an imagery intervention on participants thinking skills: one examined the 
influence of imagery on navigational abilities and spatial awareness (e.g., the 
participant imagined map-like representations), and six examined it’s influence on 
memory and new learning (e.g., participants imagined future planned events with as 
much sensory details as possible). The remaining two studies explored the effect of 
either compassion or relaxation-based imagery exercises on mood (i.e., on levels of 
relaxation, empathy, and self-compassion). No study specifically targeted behaviour 
with its intervention, though one study measured disinhibited behaviour before and 
after treatment. Imagery was found to:  
o Improve prospective memory (i.e., a participant’s ability to remember to carry out 
intended actions in the future) in three studies that ranged in quality.  
o Improve new learning and memory in three studies; however, two of these studies 
were low in quality. 
o Improve participants memory for everyday things (e.g., names and faces) in two 
studies of moderate to strong quality. 
o Improve navigational abilities in one case study of moderate quality. 
o Have an inconsistent effect on anxiety, depression, and levels of relaxation and 
empathy, and no effect on self-compassion, across four studies that ranged in quality. 
o Show some improvements in disinhibited behaviour on questionnaires completed by 
family or staff members, but not on self-report, in one study of strong quality.  
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Conclusions 
Overall, this review tentatively suggested that imagery is an effective way of 
working psychologically with ABI groups, particularly when addressing changes in 
thinking skills. Despite promising findings in non-ABI populations, studies examining 
the impact of imagery on mood and behaviour are exceptionally sparse within ABI, 
and those that have report mixed results. It would be beneficial for future studies of 
































Empirical Study: A Values-based Intervention for Neurorehabilitation 




Psychological distress such as depression is common following ABI and is often 
more debilitating than changes experienced in thinking and physical abilities. Distress 
can impact negatively on long-term outcomes including social and occupational 
functioning, quality of life and adjustment to the injury and its consequences. It is 
suggested that interventions focusing on an individual’s values (what is truly important 
to them) can improve mood and adjustment, and lead to increased meaningful 
behaviours despite their injury. However, depression can reduce motivation for 
engaging in valued activities. In individuals without an ABI, imagery has been shown 
to increase engagement and motivation for planned activities. The current study 
therefore explored the use of a values-based intervention for individuals with an ABI 
and symptoms of depression. Mental imagery was optional and added to the 
intervention for instances where participants experienced reduced motivation to 
engage in the values-based activities discussed during therapy sessions. 
Method 
The study aimed to recruit six individuals with an ABI who were undergoing 
inpatient neurorehabilitation at one of two London hospitals. All participants were 
over the age of 18 and experiencing symptoms of depression, and were not of high 
risk (i.e., they did not present with suicidal intent or substance misuse). Participants 
took part in a values-based intervention, which aimed to increase their engagement in 
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activities that were personally meaningful to them. Measures of psychological distress 
and values-based behaviour were completed as close to daily as possible during the 
baseline period of two, three or four weeks, the intervention stage (consisting of five to 
seven sessions) and the two-week follow-up. Throughout the study participants were 
also assessed using standardised questionnaires of mood, quality of life, adjustment, 
future thinking, and behaviour. Data was analysed by comparing participant’s scores 
on each measure to their scores at earlier time points.  
Results 
Four individuals completed the intervention, with three completing follow-ups. 
The following was found: 
o All individuals demonstrated an increase in values-consistent behaviour when 
tracking specific values that were identified in early sessions (i.e., they engaged with 
more things that mattered to them). 
o Most participants reported engaging in additional values-based behaviours in 
addition to those discussed with the therapist. 
o Three out of four participants improved on at least one questionnaire post-
intervention, with the most improvement made in depression. However, findings were 
not always maintained at follow-up and were inconsistent across measures (e.g., 
participants often demonstrated a reduction in depression on standardised 
questionnaires but not on daily ratings of low mood).  
o The intervention was feasible and deemed acceptable by all participants. 
Conclusions 
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This was the first study to explore the use of a values-based intervention for 
neurorehabilitation inpatients with an ABI and symptoms of depression. The flexible 
nature of the research therapy meant that participants physical and thinking abilities 
could be considered when establishing value-based activities within sessions, 
encouraging them to engage in meaningful behaviours despite their injury. Most 
participants reported increased values-consistent behaviours and reduced symptoms of 
depression over the course of therapy. However, results were inconsistent across 
participants and measures. Additionally, study limitations including not reaching the 
desired number of participants, the sole use of self-report and the uncontrollability of 




























Chapter II: Is Imagery an Effective Method of Intervening 
Psychologically with Acquired Brain Injury (ABI) Groups? 
 
Abstract 
Individuals with an acquired brain injury (ABI) often experience a complex 
presentation of symptoms that impact on their recovery. These include physical and 
cognitive disability, reduced engagement in meaningful activities, and psychological 
distress such as depression. Supporting individuals to adjust psychologically is 
therefore likely to aid the recovery process. However, depression is associated with a 
negative bias for imagining future events, which is likely to affect the successful 
implementation of psychological and rehabilitative interventions for this group. In 
non-ABI populations, imagery is shown to be an effective way of offsetting this 
negative bias, in addition to assisting in the management of various other emotional or 
cognitive difficulties. The exploration of imagery use with ABI groups is therefore 
likely to yield multiple benefits. This review aimed to explore the effect of imagery-
based interventions on psychological outcomes of cognition, mood, and/or behaviour 
after an ABI. A literature search conducted using PsychINFO, PubMed and Web of 
Science identified 617 articles, nine of which are included in this review. The total 
sample size was 244, and a male majority was found. A narrative synthesis of findings 
tentatively showed that imagery is an effective way of working psychologically with 
individuals post-ABI, particularly when used as a cognitive strategy in Traumatic 
Brain Injury (TBI). However, research exploring its use in wider ABI populations 
(e.g., post-stroke) is lacking. Additionally, it would be beneficial to further explore the 
use of imagery interventions that target mood and behaviour related outcomes, which 
is exceptionally sparse within ABI despite promising findings in non-ABI groups. 
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Multi-centre RCTs or randomised SCEDs are recommended to establish effects 



















Acquired Brain Injury  
An acquired brain injury (ABI) is damage to the brain that occurs after birth 
and is not hereditary, congenital, degenerative, or induced by birth trauma. Possible 
causes include a traumatic brain injury (TBI) caused by an external force or non-
traumatic injuries resulting from anoxic or hypoxic events and infection-related 
diseases such as encephalitis, septicaemia, or meningitis. The causes and outcomes of 
an ABI are therefore heterogeneous in nature (Ditchman, 2017). Impairments can be 
‘temporary or permanent and cause physical, functional disability, or psychosocial 
maladjustment’ (World Health Organization, WHO; Geneva, 1996). Most ABI result 
from a TBI or stroke (Mozzafarian et al., 2016); hence, these will form the focus of the 
present review.  
 A TBI occurs when a sudden trauma causes damage to the brain. They can 
result when the head suddenly and violently hits an object, through acceleration or 
deceleration or when an object pierces the skull and enters the brain tissue (NINDS, 
2019). The most common causes of TBI are road traffic accidents (RTA) and falls 
(Peeters et al., 2015). Following a TBI, an individual may experience alterations in 
consciousness, memory loss and/or neurological symptoms such as visual changes or 
weakness in one side of the body (Diagnostic and Statistical Manual of Mental 
Disorders v; DSM-V, 2013). Studies exploring the epidemiology of TBI report a male 
predominance in cases across Europe (Anke et al., 2015; Numminen et al., 2011; 
Perez et al., 2012), the USA (Corrigan, Selassie & Orman, 2010), Australia and New 
Zealand (Myburgh et al., 2008). TBI is also reported to be more prevalent in adults 
under the age of 25 or over the age of 75 (Peeters et al., 2015). However, these 
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estimates are based on records of emergency department visits, hospital admissions 
and discharge registries, within which TBI is identified using codes of the 
International Classification of Diseases (ICD). Such classifications are pathologically 
based and are primarily intended for administrative use; consequently, their 
applications in epidemiological research are limited and incident rates are likely to be 
underestimated (Roozenbeek, Maas & Menon, 2013).  
A stroke can be caused in one of two ways: (1) an ischaemic stroke when a 
blood vessel that carries oxygen and nutrients to the brain is blocked and (2) a 
haemorrhagic stroke when the blood vessel ruptures and bleeds into the brain. In both 
cases, the blood and oxygen supply to the brain is interrupted leading to cell death 
(Stroke Association, 2018). Most strokes (87%) are ischaemic, though haemorrhagic 
strokes are reported to be most fatal (Stroke Association, 2018). Depending on the 
severity and brain regions affected by a stroke, individuals can experience changes in 
behaviour and/or a loss of function in mobility, speech and/or cognition. 
Predominantly, strokes affect older adults with an average age of 72 for men and 78 
for women. However, in the UK a quarter of strokes are experienced by working age 
adults (Stroke Association, 2018). Although some recover well from a stroke, a third of 
survivors will experience depression post-stroke and two thirds of survivors will leave 
hospital with a disability (Stroke Association, 2018). 
In the UK, an ABI is graded as mild, moderate, severe, or extremely severe 
based on measures such as the level of consciousness or Glasgow coma scale (GCS) 
(Ghajar, 2000). In most cases, a mild brain injury (GCS 13–15) is caused by a 
concussion where there is full neurological recovery, although many of these patients 
experience short-term memory and concentration difficulties. In moderate ABI (GCS 
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9–13) the patient is often lethargic or stuporous, and in severe injury (GCS 3–8) the 
individual is often comatose, unable to communicate with their environment (Ghajar, 
2000). Individuals with severe or extremely severe injuries are likely to be hospitalised. 
Those with moderate to extremely severe injuries may receive neurorehabilitation if 
there is a likelihood of neurological growth and functional repair (Headway, 2019). 
Consequences of ABI 
Many individuals with an ABI, particularly those with moderate to very severe 
injuries, experience significant temporary or permanent alterations in cognition 
(McAllister, 2011), behaviour, emotional regulation, mobility, and function (Gertler, 
Tate & Cameron, 2015). Cognitive changes can affect the domains of memory, 
attention, vision, visuospatial awareness, executive functioning (e.g., planning and 
organisation; problem solving; self-awareness and social behaviour) and processing 
speed (Arciniegas et al., 2002; Barman, Chatterjee & Bhide, 2016). Additionally, 
individuals may experience physical symptoms ranging from headaches, fatigue and 
nausea to weakness or paralysis in parts of the body (Head, 1993; Mathias & Alvaro, 
2012).  
 Post-ABI, an array of behavioural and emotional changes (e.g., irritability, 
frustration, and aggression) reflect a combination of organic damage and 
psychological reactions to the injury and its consequences (Tyerman, 2016). Such 
changes vary significantly across individuals; however, a growing body of research 
outlines a general reduction in mood and quality of life (QOL) post injury (Bryant et 
al., 2010). Reported difficulties include increased lability (a loss of emotional control) 
and post-traumatic stress disorder (PTSD), with up to 40% of mild to moderate ABI 
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patients also experiencing clinical levels of anxiety and/or depression (Seel & 
Kreutzer, 2003; Wellisch, Kaleita, Freeman, Cloughesy, & Goldman, 2002). 
Additionally, post-injury, individuals often experience feelings of loss and denial, 
negative changes in self-concept and difficulties accepting their new circumstances 
(Beadle, Ownsworth, Fleming, & Shum, 2016; Carroll & Coetzer, 2011). Impaired 
insight into their difficulties is likely to further hinder recovery and community 
reintegration (Ownsworth et al., 2007).  
 The combined effects of cognitive, physical, sensory, behavioural, and 
emotional changes mean that many individuals with an ABI face significant 
challenges in their work, leisure and social activities, and in their relationships. 
Individuals frequently struggle to engage in activities of daily living (ADLs) or enjoyed 
activities (Ditchman, 2017), reintegrate into the community, and return to 
employment (Yeates, 2018). For instance, stroke survivors are reported to be two to 
three times more likely than the general population to be unemployed eight years 
post-injury (Stroke Association, 2018). Furthermore, unemployment is substantially 
higher after a TBI for people who were employed when injured than in the general 
population, with the literature reporting a 42% unemployment rate versus an 
expected 9% risk of unemployment (Machamer, Temkin, Fraser, Doctor & Dikmen, 
2005). 
Recovery Journey 
Generally, ABI outcomes are assessed six months post injury as this is the most 
opportune time for progress to be made due to brain plasticity (Sohlberg & Mateer, 
2001). However, whilst approximately 85% of recovery occurs within this period, 
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further recovery may occur later (Maas, Stocchetti & Bullock, 2008) depending on 
injury factors (e.g., injury type and severity) and demographic influences such as pre-
morbid functioning, personality, and age (Brown & Nell, 1992; Maas, Stocchetti & 
Bullock, 2008). Hence, recovery is an idiosyncratic journey that varies widely between 
individuals.  
For numerous reasons psychological interventions play an important role 
throughout the recovery journey. Firstly, because the effects of ABI are long-lasting 
and, in some cases, permanent (WHO, 1996); and secondly, because psychological 
distress, such as depression, is common following ABI (Juengst, Kumar, & Wagner, 
2017), which can negatively impact long-term functional outcomes (Cullen et al., 
2018). However, research exploring the effectiveness of existing psychological 
interventions often produces mixed findings (Gertler et al., 2015; Wiart, Luaute, 
Stefan, Plantier & Hamonet, 2016). For instance, Gertler et al. (2015) reviewed RCTs 
for non-pharmacological interventions for adults with depression and TBI, within 
which four studies explored the use of various psychological therapies: CBT (Ashman, 
2014; Fann, 2015; Simpson et al., 2011); mindfulness-based cognitive therapy 
(Bedford et al., 2013), and psychotherapy (Ashman, 2014). Interventions were found 
to be no more effective than no treatment. Similar findings are also reported in the 
treatment of post-stroke depression: interventions including CBT (Lincoln & 
Flannaghan, 2003), motivational interviewing (Watkins et al., 2007) and 
psychotherapy with psychoeducation (Zhao, 2004) were not found have a significant 
effect on depressive symptoms (Cochrane systematic review; Hackett, Anderson, 
House & Xia, 2008). Conversely, CBT has shown some value in reducing symptoms 
of depression (Fann, Hart & Schomer, 2009) and anxiety (Soo & Tate, 2007) following 
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TBI, as well as both depression and anxiety post-stroke (Waldron, Casserly & 
O’Sullivan, 2013).  
Such mixed findings may be explained by methodological limitations within 
studies such as small sample sizes and high dropout rates, in addition to the 
questionable suitability of certain approaches for individuals with a brain injury. For 
instance, it has been argued that cognitive impairment, common within ABI, may 
make it difficult for individuals to engage with the cognitive restructuring component 
of CBT (Cullen et al., 2018; Kangas & McDonald, 2011; Soo, Tate & Lane-Brown, 
2011). Furthermore, depression is associated with a negative bias for imagining future 
events (Murphy et al., 2019), which, along with the discussed cognitive limitations, 
likely impacts on the successful implementation of psychological and rehabilitative 
interventions. For example, depressed individuals may be less motivated to engage in 
behavioural interventions, predicting negative results and withdrawing from 
rehabilitation and previously enjoyed activities. In non-ABI populations, imagery is 
shown to be an effective way of offsetting the impact of this negative bias, motivating 
people to partake in desired behaviours (Renner et al., 2019). Moreover, as outlined 
below, imagery-based approaches are reported to be effective in the management of 
various other emotional (e.g., PTSD, social anxiety) or cognitive (e.g., memory, 
learning and planning) difficulties. Thus, the exploration of imagery use with ABI 
groups is likely to yield multiple benefits. 
Mental Imagery Interventions: Non-ABI Population 
Imagery is defined as the ‘simulation or re-creation of perceptual experience 
across sensory modalities’ (Pearson, Deeprose, Wallace, Heyes & Holmes, 2013). This 
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definition is broad and can encompass a range of psychological and non-psychological 
interventions (e.g., motor imagery in physiotherapy). However, the present review will 
focus on imagery as utilised within psychological interventions (i.e., those focusing on 
either cognition, mood, or behaviour). 
Imagery and Cognition 
Mental imagery underlies numerous cognitive skills, including the ability to 
remember, plan, navigate and make decisions (Pearson, Naselaris, Holmes & Kosslyn, 
2015). It is argued that mental images can also replace perceptual stimuli during 
learning tasks. Typically, perceptual learning requires an individual to repeatedly 
perform a perceptual detection or discrimination task; however, research has 
demonstrated that imagining each component of a given task, without physical 
enactment, can also enhance learning and later performance (Tartaglia, Bamert, Mast 
& Herzog, 2009). It is therefore reasoned that mental imagery functions similarly to 
sensory perception (Pearson et al., 2015; Tartaglia et al., 2009) and can generalise 
from the imagined to the perceptual content (e.g., Lewis, O’Reilly, Khuu & Pearson, 
2013). Furthermore, when assessed on tasks of visual working memory, participants 
reported using one of two methods to complete a memory task: (1) picking out details 
of the presented stimuli and encoding them phonologically or verbally (e.g., Keogh & 
Pearson, 2014), and (2) creating a mental image of the presented stimuli that is then 
compared to the subsequent test stimuli (e.g., Harrison & Tong, 2009). However, 
individuals with stronger mental imagery skills demonstrated increased precision and 
higher capacity on assessment of visual working memory only, not on tasks of verbal 
working memory (Keogh & Pearson, 2014).  
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Imagery and Mood 
Images can evoke powerful emotional states (Holmes & Matthews, 2010), 
evidenced by their role in numerous psychological disorders: PTSD, whereby potent 
emotions are induced by imagery in the form of flashbacks to a traumatic event 
(Holmes, Grey & Young, 2005); social phobia (Hirsch et al., 2006); schizophrenia 
(D’Argembeau, Raffard & Van der Linden, 2008); bipolar disorder (Holmes, Geddes, 
Colom & Goodwin, 2008), and depression (Wheatley et al., 2007). Mental images are 
widely believed to contribute to the onset and maintenance of these diagnoses (e.g., 
Clark & Wells, 1995; Ehlers & Clark, 2000), and hence, mental imagery underlies 
many of the available clinical treatments. This includes, but is not limited to, ‘imagery 
rescripting’ in CBT (e.g., Holmes, Arntz & Smucker, 2007) and schema focussed 
therapy (e.g., Giesen-Bloo et al., 2006), as well as relaxation and compassionate 
imagery. For example, a transdiagnostic therapy group for self-critical individuals who 
experienced low self-esteem utilised imagery exercises, such as the ‘safe place’ and 
‘compassionate self’, reporting significantly reduced symptoms of depression and 
heightened self-esteem on post-group measures (Andersen & Rasmussen, 2017). 
Imagery and Behaviour 
Motivating engagement in specific behaviours is often challenging. Cognitive 
interventions are frequently adopted in attempt to elicit behaviour change, providing 
individuals with the risks and benefits of various alternative actions, and hoping that 
this will inform their decisions (Renner, Murphy, Ji, Manly & Holmes, 2019). 
However, such cognitive analysis often fails (Marteau, Holland & Fletcher, 2012). 
Instead, it is argued that using mental imagery to “pre-experience” future planned 
 23 
behaviours, and the emotional experience associated with them, can increase 
motivation and subsequent engagement (Holmes, Blackwell, Burnett Heyes, Renner 
& Raes, 2016; Renner et al., 2019). Imagery-based interventions have been shown to 
positively impact motivation across a range of maladaptive behaviours and 
psychological disorders (e.g., May, Andrade & Kavanagh, 2015). In one study, 72 
healthy individuals identified six activities they wanted to complete over the following 
week, before being randomly assigned to either a session of motivational imagery, an 
activity reminder control condition, or a no-reminder control condition. Relative to 
control groups, the motivational imagery group reported higher levels of motivation 
as well as anticipated pleasure and reward for their planned activities (Renner et al., 
2019).  
Mental Imagery Interventions: ABI Population 
The literature exploring the use of imagery is currently limited in the ABI 
population; however, findings suggest that when utilised as a cognitive strategy, 
imagery can lead to increased skill generalisation to novel environments (Liu et al., 
2009) and positively impact attentiveness (Liu et al., 2004), creativity, planning and 
self-monitoring (Braun et al., 2008). Nevertheless, no reviews have explored the use of 
mental imagery in ABI and its impact on psychological outcomes specifically. The 
present review therefore aimed to systematically review if imagery is an effective 
method of intervening psychologically with ABI groups. To be considered a 
psychological intervention, primary outcome measures had to cover the domains of 
cognition, mood and/or behaviour. Mood was classified broadly (e.g., depression, 
anxiety, stress, negative affect, emotional distress); hence, clinical criteria did not need 
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to be met for eligibility. This was in accordance with recommendations that advocate 
for a transdiagnostic approach when working with ABI (Robinson et al., 2019).  
Method 
Search Strategy 
A comprehensive search of both psychological and medical literature was 
conducted using three electronic databases: Psychinfo (from 1986-present), PubMed 
(from 1975-present) and Web of Science (from 1970-present). All searches were 
informed by PRISMA guidelines and completed in consultation with a library search 
expert. The search terms (see Table 1) were applied to titles and abstracts using the 
filters of ‘Adults’, ‘Humans’ and ‘English’ for PsychINFO and PubMed. ‘Peer-
reviewed’ was also selected for PsychINFO. The filter ‘English’ was used for Web of 
Science and the psychology databases were searched. For all databases, a ‘not’ search 
term excluded physiotherapy papers exploring ‘motor-imagery’ and medical literature 
around brain imaging (i.e., magnetic resonance imaging, MRI, or positron emission 
tomography, PET). To ensure that this did not screen out eligible studies, an initial 
search was conducted including these search terms and their titles were reviewed. On 
initial review, older studies (i.e., those published prior to 2010) were often unavailable 
despite multiple attempts to access them. Therefore, only papers published from 2010 
onwards were included as these could most thoroughly be reviewed. The final search 
was run in January 2021. 
Table 1 




“TBI” or “ABI” or “Brain injur*” or “Head injur*” or “Stroke” or 
“Cerebrovascular accident” or “CVA” or “Cerebrovascular apoplexy” or 
“Vascular accident” or “Brain haemorrhage” 
AND  
“mental imagery” or “imagery” or “imagine” or “imagination” or “visualisation” or 
“visualise” or “self-imagination” 
NOT 
“MRI” or “magnetic resonance imaging” or “imaging” or “PET” or “Positron 
Emission Tomography” or “motor imagery” 
In addition to these searches, the relevant reference lists of retrieved publications were 
examined for further eligible studies.  
Study Eligibility Criteria 
Studies were required a) to have samples of adults over the age of 18 with a 
diagnosed ABI b) to evaluate a psychological intervention that included mental 
imagery c) to utilise outcome measures specific to psychological interventions (i.e., 
cognition, mood, or behaviour) d) to use quantitative data analysis e) to have been 
published in a peer-reviewed journal f) to be available in English and g) to have been 
published post 2010. Studies were excluded if they did not meet the outlined criteria, 
for example studies that used qualitative methodologies or described non-
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psychological imagery interventions. There were no restrictions on country of 
publication. 
Study Selection 
A total of 617 studies were retrieved: 202 from PsychINFO, 205 from PubMed 
and 210 from Web of Science. One additional study was hand selected. Once 
duplicates had been removed, 513 titles and abstracts were screened by the primary 
researcher against the eligibility criteria. Although 12 papers appeared relevant, only 
11 full-text papers were fully assessed due to one study being unobtainable. Two 
studies did not meet inclusion criteria as they contained a non-psychological imagery 
intervention (i.e., they focused on motor imagery as used in occupational or 
physiotherapy). Nine were deemed eligible (see Figure 1). A headed table outlining the 
inclusion criteria was developed to guide data extraction from the full text articles and 
to assess their eligibility.  
Figure 1  







As presented in Table 3 (Results section), data was extracted according to study 
design, participant demographics (e.g., age and cause of ABI), setting, intervention 
details (e.g., format, duration, frequency, and content), delivery method (e.g., group or 
one-to-one), control or comparator details, outcome variables, outcome data, quality 




To assess study quality, the Quality Assessment Tool for Quantitative Studies 
(QATQS) was used (Effective Public Health Practice Project; Thomas, Ciliska, 
Dobbins & Micucci, 2004). This is a standardised tool developed for quantitative 
studies in health care settings, providing an overall methodological rating of strong, 
moderate, or weak according to six predefined areas (Table 4, Results section). It holds 
good test re-test reliability (Armijo-Olivo, Stiles, Hagen, Blondo & Cummings, 2012; 
Thomas et al., 2014) and acceptable content validity (Thomas et al., 2014). 
Process of Data Synthesis 
Data was synthesised narratively using guidance by Popay et al. (2006). It 
would have been misleading to attempt an overall calculation of treatment effect as 
the identified studies varied significantly in design, outcome measures and data 
analysis; consequently, they did not meet the homogeneity required to complete a 
meta-analysis (Bundell, 2014). However, where possible, effect sizes (ES) were 
included using either Cohen’s d, Cohen’s w, eta squared (η2) or partial eta squared 
(ηp2), in line with the study’s reporting. Typically, in studies using ANOVAs, partial 
eta squared is reported. Partial eta square partials out the effects of other independent 
variables and is therefore recommended over eta squared when comparing studies 
(Cohen 1973; Richardson, 2011). Where a study failed to report ES, despite the 
available data, Cohen’s d was calculated by dividing the mean difference by the 
pooled standard deviation for group by time calculations, or by baseline standard 
deviation for pre-post calculations. In some cases, ES could not be calculated due to 
limitations of reported data (e.g., means or raw scores not being provided). Table 2 
outlines effect size classifications; though, whilst these are helpful benchmarks, they 
should not be interpreted too rigidly (Thompson, 2007). 
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Table 2 
Effect Size Classifications in accordance with Cohen (1988) 
Statistic Small Medium Large 
Cohen’s d 0.20 0.50 0.80+ 
Cohen’s w 0.10 0.30 0.50 
Eta Squared (η2) 0.02 0.13 0.26 
Partial Eta Squared (ηp2) 0.01 0.06 0.14 
Results 
As outlined in Table 3, nine studies met inclusion criteria. The studies varied 
in their design with one case study (Boccia et al., 2019), one randomised controlled 
trial (RCT) (Chiaravalloti et al., 2016) and one AB-BA crossover design (Raskin et al., 
2019). Of the remaining studies, three adopted within-group experimental designs, 
whereby a participant’s performance was compared under different conditions (Grilli 
& Glisky, 2010; Grilli & Glisky, 2011; Grilli & McFarland, 2012); and three used a 
between-group experimental design, comparing an intervention group to a 
control/comparator group posttreatment (Campbell et al., 2019; O’Neill & 
McMillan, 2012; Potvin et al., 2011). 
Recruitment  
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Five studies recruited participants from the USA, two from Scotland, one from 
Italy and one from Canada (see Table 2). Except for three studies (Boccia et al., 2019; 
Grilli & Glisky, 2011; Potvin et al., 2011), all studies recruited from multiple 
recruitment sites. Six studies recruited participants from neurorehabilitation wards or 
clinics (Boccia et al., 2019; Campbell et al., 2019; Chiaravalloti et al., 2016; O’Neill & 
McMillan, 2012; Potvin et al., 2011; Raskin et al., 2019), six from brain injury 
community groups (Campbell et al., 2019; Chiaravalloti et al., 2016; Grilli & Glisky., 
2010; Grilli & McFarland, 2011, O’Neill & McMillan, 2012; Raskin et al., 2011) and 
four from existing databases or laboratory participant pools (Chiaravalloti et al., 2016; 
Grilli & Glisky, 2010; Grilli & Glisky, 2011; Grilli & McFarland, 2011). Studies using 
a between-group design recruited their intervention and control groups from the same 
sites (Campbell et al., 2019; Chiaravalloti et al., 2016; O’Neill & McMillan, 2012; 
Potvin et al., 2011). Three studies used the same recruitment site(s) (Grilli & Glisky., 
2010; Grilli & Glisky, 2011; Grilli & McFarland, 2011), with Grilli and Glisky (2011) 
including 11 participants who also took part in their 2010 study.  
 The overall sample size was 244. Study sample sizes varied from one (Boccia 
et al., 2019) to 69 (Chiaravalloti et al., 2016). Most studies using an intervention and 
control/comparator group divided their samples evenly (Campbell et al., 2019; 
Chiaravalloti et al., 2019; Grilli & Glisky, 2010; O’Neill & McMillan, 2012; Raskin et 
al., 2019), except for one (Potvin et al., 2011) in which two-thirds of participants were 
allocated to the control group. Most patients were outpatients, with only participants 
in Campbell et al. residing in hospital. It is not reported whether participants in 




The mean ages of intervention participants with an ABI ranged from 35 to 49 
years. For control participants, mean ages ranged from 30 to 49 years. All studies 
reported a male majority, representative of TBI which mainly occurs in men (Anke et 
al., 2015). In terms of between-group (i.e., control versus intervention) gender 
comparisons at baseline, three studies did not report a significant between group 
difference (Campbell et al., 2019; Chiaravalloti et al., 2016; O’Neill & McMillan, 
2012), one failed to report the percentage of males in the control group (Grilli & 
Glisky, 2010), and two did not conduct statistical comparison (Potvin et al., 2011; 
Raskin et al., 2019). In O’Neill and McMillan, more than two thirds (70.8%) of the 
total sample fell into the three most deprived deciles as measured using the Scottish 
Index of Multiple Deprivation (Scottish Government, 2009).  
Brain Injury  
Six studies selectively recruited participants who had received a TBI diagnosis 
(Boccia et al., 2019; Campbell et al., 2019; Chiaravalloti et al., 2016; O’Neill & 
McMillan, 2012; Potvin et al., 2011; Raskin et al., 2019). Three studies (Grilli & 
Glisky, 2010; Grilli & Glisky, 2011; Grilli & McFarland, 2011) recruited participants 
with neurological damage of mixed etiology; within these, 70 to 75% of participants 
had experienced a TBI, and 25 to 30% of participants sustained their ABI due to a 
tumour, anoxia, an aneurysm, or encephalitis. No study recruited participants who 
had experienced a stroke. 
Across studies, individuals with a TBI were reported to have sustained these 
following a road traffic accident (RTA), fall or assault, with most participants having 
 32 
experienced an RTA or fall. This is reflective of previous findings that report RTA’s 
and falls as the most common causes of TBI (Peeters et al., 2015; Corrigan, Selassie & 
Orman, 2010; Myburgh et al., 2008). TBI was classified as severe in three studies 
(Boccia et al., 2019; Campbell et al., 2019; O’Neill & McMillan, 2012), and moderate 
to severe in three studies (Chiaravalloti et al., 2016; Potvin et al., 2011; Raskin et al., 
2019). However, the specifications used to classify injuries as ‘severe’ varied from 
experiencing post-traumatic amnesia for at least one day (O’Neill & McMillan, 2012) 
to being comatose for one month (Boccia et al., 2019) to meeting thresholds on the 
GCS (Campbell et al., 2019; Chiaravalloti et al., 2016; Raskin et al., 2019). Injury 
severity is therefore likely to be heterogenous across studies, despite the same severity 
labels being utilised. In three studies using a TBI control or comparator group, no 
significant differences were noted in injury severity between groups (Chiaravalloti et 
al., 2016; O’Neill & McMillan, 2012; Potvin et al., 2019). One study failed to report 
injury severity by group (Campbell et al., 2019). Remaining studies did not specify 
brain injury severity (Grilli & Glisky., 2010; Grilli & Glisky, 2011; Grilli & McFarland, 
2011). 
In some studies, the cognitive impact of ABI was measured through 
neuropsychological testing, including assessment of memory using the Weschler Memory 
Scale and the Weschler Adult Intelligence Scale (used by Grilli & Glisky, 2010; Grilli & 
Glisky, 2011; Grilli & McFarland, 2011), the Test Ecologique de Memoire Prospective 
(TEMP; used by Potvin et al., 2011) and the Memory Assessment Scales – Prose Memory 
(MAS-PM; used by Chiaravalloti et al., 2016). In Grilli and Glisky (2010), all 
intervention participants demonstrated a memory impairment, scoring at least one 
standard deviation (i.e., 15 points) below their expected score on the General Memory 
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Index (GMI). Most participants (57%) were reported to be experiencing a severe 
memory disorder. Similarly, in Grilli and McFarland (2011) all participants 
demonstrated memory impairment on the GMI compared to their estimated 
premorbid functioning, and in Grilli and Glisky (2011), all participants experienced a 
self-reported decline in memory. In Potvin et al., participants demonstrated reduced 
performance (>1 standard deviation below their expected score) on tasks of 
prospective memory (PM), and in Chiaravalloti et al., all participants demonstrated 
impaired new learning and memory. Further tests of cognitive functioning were 
reported in most studies. In Raskin et al. (2019), participants performed poorly on 
tests of complex attention, executive functioning, and retrospective memory pre-
treatment; and in Boccia et al. (2019) deficits were found in visuo-spatial learning and 
delayed recall, and in visual, spatial, and verbal memory in ecological contexts. No 
studies reported a significant difference between treatment and control groups in 
terms of baseline cognitive functioning. 
In one study (O’Neill & McMillan, 2012), the impact of ABI on empathy was 
assessed pre-treatment. All participants scored at least one standard deviation below 
the average for published norms on the Basic Empathy Scale (<54.5 for males; <67 for 
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(1) Corsi block tapping 
test (CBTT) 
 
(2) Walking Corsi Test 
(WalCT) 
 
(3) Cognitive Map Test 
(CMT) 
 
(4) Navigational tasks in 
real environment 
 
(1) CBTT  
Posttreatment:  
Learning ns (t=1.07, p=.15)  
Delayed recall ns (t=-.28, 
p=.39) 
Follow-up: 
Learning ns (t=.73, p=.24)  





Learning ns (t =.58, p=.28) 











(6) Complete Visual 
Mental Imagery Battery 
(CVMIB) 
Learning ns (t=-1.002, p=.16)  





Learning ns (z=-0.81, p=.46)  
Recall ns (z=-1.34, p=.44) 
Follow-up:  
Learning s (z=2.18, p=.009)  
Recall ns (z=-1.565, p=.17)  
 
(4) Navigational tasks 
Posttreatment: 
100% effectiveness on map-
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(3) State Trait Anxiety 
inventory (STAI)  
 




Group differences  
 
Posttreatment: 
(1) Empathy ns (F(1,21)=.577, 
p=.46, d=.32) 
(2) Self-compassion ns 
(F(1,21)=.426, p=.58, d=.28) 
(3) Anxiety ns (M-W, 
U=67.50, p= .35, d=.31) 
(4) Relaxation ns 
(F(1,21)=.131, p=.72, d=.15)  
Combined groups (CFI & RI 
groups together) 
Posttreatment:  
(1) Empathy ns (t(23)=-1.945, 
p=.064, d=.35) 
(2) Self-compassion ns (t(23)=-
.189, p=.85, d=.03) 
(3) State anxiety s (Wilcoxon 
S-R; T=40, p<.05, r=.29, 
d=.32)  
(4) Relaxation s (Wilcoxon S-
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(1) Memory Assessment 
Scales, Prose Memory 
(MAS-PM)  
 


























Memory enhanced in Tx vs 
control (F(1,69)=4.45, p<.05, 
ηp2=.064) 
RCI:  
Tx: 23%; Control: 9% 
Follow-up: 
Effect of group (Tx vs control) 
ns (F(1, 65)=1.85, p>.05, 
ηp2=.028)  
Effect of time (Posttreatment 
vs follow-up) ns (F(1, 65)=.33, 
p>.05, ηp2=.005) 
Interaction s (F(1, 65)=3.92, 
p=.05, η2=.057)  
 
Booster sessions: 
Effect of group (Booster vs 
non-booster) ns (F(1, 
31)=.047; p>.05; ηp2=.002)  
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Effect of time (Posttreatment 
vs follow-up) ns (F(1, 
31)=.186; p>.05; ηp2=.006)  
Interaction ns (F(1, 31)=.428; 
p>.05; ηp2=.014) 
 
(2) CVLT-II  
Posttreatment: 








PM enhanced in Tx relative 
to control (x2(1)=7.36, 
p=.025, Cohen’s w=.43) 
 
(2) FrSBe  
Posttreatment: 
Informant-reported 
improvements in disinhibition 
in Tx (F(1, 31)=6.86, p<.05, 
η2=.046) not the control. 
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Self-report measures for Tx 
and control ns 
 
(3) STAI  
Posttreatment:  
Anxiety in Tx relative to 
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Effect of condition s (F(3, 
39)=43.15, p<.001, η2=.77).  
Effect of emotion ns (F(1, 
13)=3.61, p=.08, η2=.27)  
Interaction ns (F(3, 39)=2.08, 
p=.12)  
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Effect of delay time s (F(1, 
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Interaction ns (F < 1) 
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saying them out 
loud prior to task. 
 
 




83% participants failed to 
perform a single PM task in 
the rote-rehearsal condition. 
41% participants failed to 
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Self-report scales: 
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(Median (range) 
reported): 

















(3) The Relaxation 
Scale (RS) 
(2) Self-compassion ns 
(H(1)=.00, p= .95)  
(3) Relaxation ns (H(1)=.25, 
p=.62, d=.38) 
Combined groups (CFI & RI 
groups together) 
Posttreatment: 
(1) Empathy ns (t(23)=.78, 
p=.45, d=.32) 
(2) Self-compassion ns 
(Wilcoxon T=78.00, p = 0.07, 
r = –.26). 
(3) Relaxation ns (Wilcoxon 
T=71.00, p=.20)  
Within-group treatment effects 
CI group:  
(1) Empathy ns (t(11)=1.18, 
p=.13, d=.71) 
(2) Self-compassion ns 
(T=25.50, p=.14) 
(3) Relaxation ns (T=27.50, 
p=.62). 
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RI group:  
(1) Empathy ns (t(11)=.09, 
p=.93, d=.05) 
(2) Self-compassion ns 
(T=17.00, p=.15) 
























































































(1) Digit Symbol; (2) 
Cancellation Task; (3) 
Trail Making Test – 
Part A; (4) Digit Span; 
(5) Rey Auditory Verbal 
Learning Test; (6) Brief 
Visuospatial Memory 
Test; (7) Trail Making 




Time (pre/post) s (F(1, 
27)=19.94, MSE=42.17, 
p<.05, η2=.43) 
Group (treatment/control) ns 
(F(1, 27)=.00, MSE=662.96, 
p>.05, η2=.00) 




Tx pre- to post-treatment s 












Fluency; (9) WISC-III 
Mazes; (10) Stroop; (11) 
Visual Discrimination 
Task; (12) Semantic 
Association Task; and 





(1) Beck Anxiety 
Inventory (BDI) 
 
(2) Beck Depression 
Inventory 
 




Control pre- to post-






Across groups digit symbol 
test s (F(1, 27)=5.64, p<.05). 





Effect of time ns 
Effect of group ns 
Interaction ns (p>.10).  
 
Pre-post anxiety scores 
decreased for Tx group 




Effect of time s (F(1, 27)= 
5.11, MSE=19.57, p<.05, 
η2=.16)  
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Effect of group ns (F(1, 
27)=0.29, MSE=91.19, 
p>.05, η2=.01) 
Interaction s (F(1, 27)=5.64, 
p<.05, η2=.31) 
 
Pre-post depression scores s 
decreased for Tx group 
(t(9)=3.45, p<.05, d=.86), not 
the control (t(28)=-1.04, 
p<.05, d=.25).  
 
(3) CAPM  
Posttreatment Tx: 
Decrease in self-reported PM 
failures s (t(9)=2.44, p<.05, 
d=.63) 
Decrease in relative-rated 




Self-reported failures ns 
(t(18)=1.48, p>.05, d=.38) 
Relative reported ns 
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(1) Trail Making Test A 
and B 
 
(2) The Brief Test of 
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(1) The Prospective 
Memory Questionnaire 
 








All participants showed an 
increase in the length of time 
that they were able to recall 




PM improved after active 
treatment (p<.001, d=1.52) 




relative to post-intervention 
(d=.46) 
Superior performance relative 





Attention s (p<.01, d=.46)  
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(4) Personal diaries 
Executive functioning s 
(p<.01, d=1.60) 





(1) Prospective Memory 
Questionnaire (d=.52) 
(2) Everyday Memory 
Questionnaire (p=.022, 
d=.57)  
(3) WHO-QoL-BREF (d=.62) 
(4) Diary Measure (d=1.12) 
 
Note. ns=non-significant; s=significant; RTA=Road Traffic Accident; Tx=Treatment Group; IRCCS=Scientific Institute for Research, 
Hospitalization and Healthcare; PM=Prospective Memory. Boccia et al. (2019) analysed data using a Crawford analysis (i.e., comparing 
the participant’s baseline, post-intervention, and follow-up results to a normative sample for each of the dependent variables). At baseline, 
the participant significantly differed from normative samples on all the reported measures, indicating impaired performance compared to 
their expected abilities. Therefore, in this case, non-significant results at post-treatment and follow-up demonstrate improved 
performance that was then in line with normative samples, supporting the effectiveness of the intervention. Alternatively, for all other 
studies, it is significant results that support intervention effectiveness. In their analysis Campbell et al. (2019) and O’Neill and McMillan 
(2012) compared CFI and RI groups. These results are reported under ‘Group differences’. Both studies also combined the two groups’ data, 
analysing pre- to post-outcomes for CFI and RI groups combined. This was thought to represent the general effect of imagery and is 
reported under ‘Combined groups’. In Potvin et al. (2011), participants were selectively allocated to either the experimental or control group 
based on age and education to match the two groups. 
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Interventions 
Intervention duration and frequency ranged from one session (Campbell et al., 
2019; Grilli & Glisky, 2010; Grilli & Glisky, 2011; Grilli & McFarland, 2011; O’Neill 
& McMillan, 2012) to weekly or bi-weekly sessions over either an 8-week (Boccia et 
al., 2019), 10-week (Chiaravalloti et al., 2016; Potvin et al., 2011) or six-month period 
(Raskin et al., 2019). All interventions were provided in a one-to-one format, as 
recommended in ABI due to differing cognitive impairments (Kangas & McDonald, 
2011). The content of imagery interventions varied considerably across studies.  
Three studies explored the use of ‘self-imagining’ as a memory and learning 
strategy. Participants imagined a scene described by the researcher using as much 
sensory detail as possible (Grilli & Glisky, 2010; Grilli & Glisky, 2011; Grilli & 
McFarland, 2011). Raskin et al. (2019) asked participants to imagine a PM task/event 
from a personal perspective, using questions to guide imagery such as ‘What do you 
see?’, ‘What do you hear?’ and ‘How do you feel?’ Similarly, Potvin et al. (2011) 
utilised a PM intervention, divided into five phases: (1) understanding PM functioning, 
(2) training to visualise simple images (objects and actions), (3) learning visual imagery 
techniques, (4) applying visual imagery in PM, and (5) applying visual imagery in 
everyday situations. Boccia et al. (2019) used an Imagery-Based Treatment (IBT), 
which was tailored to the participants navigational difficulties. Imagery training was 
provided, and the participant was taught to rapidly generate mental images before 
being asked to generate and retrieve navigational images of landmarks and routes, 
and environmental map-like representations. Chiaravalloti et al. (2016) used the 
modified Story Memory Technique (mSMT), a highly manualised intervention that 
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also teaches context and imagery to facilitate new learning. Finally, two studies 
(Campbell et al., 2019; O’Neill & McMillan, 2012) compared compassion-focused 
imagery (CFI) to relaxation imagery (RI) using scripted guidance that was designed to 
support ABI related deficits (e.g., simplified instructions, slowed delivery). Sessions 
followed a similar format including repetition of the CFI or RI exercises and two 
guided-reflection components. CFI comprised of sections on the ‘felt sense’ of 
compassion and the ‘compassionate calm self’. RI comprised of sections on ‘becoming 
the calm self’ and generating a ‘special relaxing place’. 
Control Groups 
Three studies used control groups. In Chiaravalloti et al. (2016), the control 
group met with the therapist at the same frequency as the treatment group and 
engaged in non-training orientated tasks. In Potvin et al. (2011), participants were 
informed of their neuropsychological test results and received a brief 
psychoeducational intervention exploring behavioural and compensatory strategies. 
Finally, in Raskin et al. (2019), control participants followed PM training without 
imagery.  
 Five studies used a comparator condition (Campbell et al., 2019; Grilli & 
Glisky, 2010; Grilli & Glisky, 2011; Grilli & McFarland, 2011; O’Neill & McMillan, 
2012). As outlined above, Campbell et al. and O’Neil and McMillan compared CFI to 
RI. In the remaining three studies, a within-group design was utilised (i.e., all 
participants took part in all conditions). In Grilli and Glisky (2010), individuals’ 
performance under the ‘self-imagining’ condition was compared to their performance 
under a ‘structural baseline condition’ and ‘semantic processing condition’. In these 
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two conditions, participants were asked to remember verbal or written sentences 
presented to them using strategies such as counting the number of syllables in the 
sentence or checking if the sentence ‘fit’ into a story that was presented with it. In 
Grilli and Glisky (2011), ‘self-imagining’ was compared to three comparator 
conditions: (1) ‘visual imagery’: participants were instructed to form a visual image of 
the target object in a specified spatial location and maintain the image for the 
duration of the trial; (2) ‘other imagining’: participants were instructed to imagine, 
with as much detail as possible, another individual interacting with the target object in 
the spatial location, and (3) ‘semantic elaboration’: participants were instructed to 
generate a sentence that incorporated the object and spatial location in a meaningful 
way and to say the sentence aloud. In Grilli and McFarland, ‘self-imagining’ was 
compared to a ‘rote-rehearsal’ condition in which participants rehearsed PM task 
instructions by saying them out loud prior to completing the task. Boccia et al. (2019) 
did not use a control or comparator group, instead comparing the participants’ pre, 
post and follow-up cognitive test scores to published neuropsychological norms.  
Quality Assessment 
Four studies used manualised or scripted interventions (Campbell et al., 2019; 
Chiaravalloti et al., 2016; O’Neill & McMillan, 2012; Raskin et al., 2019), and four 
used computerised interventions (Grilli & Glisky, 2010; Grilli & Glisky, 2011; Grilli & 
McFarland, 2011; Potvin et al., 2011). Whilst this makes it easier to adhere to 
protocol, there is no suggestion that adherence was formally monitored in any study. 
One study (Boccia et al., 2019) based their intervention on cognitive models of spatial 
navigation (e.g., Siegel & White, 1975; Wang & Spelke, 2002; Wolbers & Wiener, 
2014) as well as the imagery intervention used by Kaschel et al. (2002); however, they 
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failed to monitor consistency between the study treatment and previous models and 
interventions.  
Therapist Training 
Facilitator training and expertise was not reported in two studies (Boccia et al., 
2019; Raskin et al., 2019). Four further studies also fail to provide training 
information; however, they describe computerised interventions, less likely to be 
influenced by facilitators (Grilli & Glisky, 2010; Grilli & Glisky, 2011; Grilli & 
McFarland, 2011; Potvin et al., 2011). In one study (Chiaravalloti et al., 2016), 
specific details about facilitator qualifications were not provided; though, it is reported 
that all facilitators received training from the study co-ordinator and a PhD level 
neuropsychologist. A trained clinical neuropsychologist was used in one study 
(Campbell et al., 2019) and a final year clinical psychology trainee was used in 
another (O’Neill & McMillan, 2012).  
Follow-up 
Three studies used follow-up periods. These varied in length: six months 
(Chiaravalloti et al., 2016), eight months (Boccia et al., 2019) and one year (Raskin et 
al., 2019). In Chiaravalloti et al. fifty percent of intervention participants were 
allocated to the ‘booster’ group and completed follow-up measures. Booster sessions 
focused on applying participants newly acquired imagery skills to real-world 
situations. In Boccia et al. neuropsychological outcomes were repeated at follow-up, as 
well as immediately pre – and post – intervention. Similarly, in Raskin et al., the one-
year follow-up allowed an experimenter (with no knowledge of treatment condition) to 
repeat outcome measures for all participants.  
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Quality Rating  
As outlined in Table 4, the overall quality ratings of studies ranged from Weak 
to Strong according to the EPHPP tool (Thomas et al., 2004). To reach these ratings, 
the tool considers six study factors: selection bias, study design, confounders, blinding, 
data collection methods, and withdrawals and dropouts. The highest quality studies 
were (1) Chiaravalloti et al. (2016), an RCT, and (2) Raskin et al. (2019), an AB-BA 
crossover design. Across studies, main areas of weakness included the study design, 
blinding and data collection methods, with three studies failing to provide pre-post 
outcomes and instead comparing participant performance across experimental 
conditions (Grilli & Glisky, 2010; Grilli & Glisky, 2011; Grilli & McFarland, 2011). All 
studies made attempts to reduce selection bias and only two studies reported any 
participant withdrawals. Attrition rates were reported in terms of the number of 
dropouts (Grilli & Glisky, 2010), or the number of withdrawals in addition to the 
reasons associated with them (Chiaravalloti et al., 2016).  
The EPHPP tool also provided guidance for the evaluation of intervention 



















Boccia et al. (2019) 
 
Moderate Moderate  Moderate Weak Strong N/A Moderate 
Campbell et al. (2019) 
 
Moderate Strong Weak Strong Moderate N/A Moderate 
Chiaravalloti et al. 
2016) 
 
Moderate  Strong Strong Strong Strong Moderate  Strong  
Grilli & Glisky (2010) 
 
Moderate Weak Moderate  Moderate  Weak  Weak Weak 
Grilli & Glisky (2011) 
 
Moderate  Weak Moderate  Moderate  Weak N/A Weak 
Grilli & McFarland 
(2011) 
 
Moderate  Weak Moderate  Moderate Weak N/A Weak 
O’Neill & McMillan 
(2012) 
 
Moderate Strong Strong  Weak Moderate  N/A Moderate  
Potvin et al. (2011) 
 
Moderate  Moderate  Strong  Weak Strong N/A Moderate  
Raskin et al. (2019) 
 
Moderate  Moderate  Strong Strong  Strong  N/A Strong  
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Note. Overall quality rating: Strong = no ‘Weak’ ratings; Moderate = one ‘Weak’ rating; Weak = two or more ‘Weak’ ratings. Not 
applicable (N/A) ratings made due to these studies reporting no participant withdrawals. 
 
Table 5 
Intervention Integrity and Analysis using EPHPP tool 
Study Intervention Integrity Analysis 
 % pts receiving 
allocated intervention  
80-100%/60-79%/Less 
than 60%/Can’t tell 
Was the consistency 
of intervention 
measured? 
Yes/No/Can’t Tell  
 
Is it likely that pts 
received unintended 
treatment?  








Yes/No/Can’t Tell  
 
Boccia et al. (2019) 
 
80 – 100% No  No Can’t tell N/A 
Campbell et al. (2019) 
 
80 – 100% No No Yes No 
Chiaravalloti et al. 
2016) 
 
60 – 79%  No  No Yes Yes 
Grilli & Glisky (2010) 
 
80 – 100% No  Yes Yes No 
Grilli & Glisky (2011) 
 
80 – 100% No  Yes Yes No 
Grilli & McFarland 
(2011) 
 
80 – 100% No  Yes Yes No 
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O’Neill & McMillan 
(2012) 
 
80 – 100% No  No Yes No 
Potvin et al. (2011) 
 
80 – 100% No  No Yes No 
Raskin et al. (2019) 
 
80 – 100% No  No Yes No 
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Intervention Integrity 
In most studies all participants completed the intervention. Two studies 
reported participant withdrawals: Chiaravalloti et al. (2016) acknowledged a 6% 
attrition rate between baseline and immediate follow-up, and a 19% attrition rate 
between immediate and long-term follow-ups; and Grilli and Glisky (2010) reported a 
6% overall dropout rate. Chiaravalloti et al. used an intention-to-treat analysis (Table 
5), reducing the risk of attrition bias; however, Grilli and Glisky (2010) did not, 
increasing this risk. 
No studies measured the consistency of the intervention (see Quality 
Assessment section above). For six studies, it was deemed unlikely that study 
outcomes were influenced by participants receiving an unintended intervention, either 
via contamination (the control group accidentally receiving the study intervention) or 
co-intervention (participants receiving an unintended or additional intervention). In 
the remaining three studies (Grilli & Glisky, 2010; Grilli & Glisky, 2011; Grilli & 
McFarland, 2011), the within-group design means that there is no guarantee that 
improvements in memory encoding were attributable to the ‘self-imagining’ condition 
rather than the additional and unintended use of an earlier encoding strategy. This is 
particularly relevant in Grilli and Glisky (2011), in which 11 participants had recently 
taken part in the previous study (Grilli & Glisky, 2010) and learnt different encoding 
strategies. Such limitations are not noted by the authors, perhaps because the order of 
conditions was counterbalanced across participants, which partially controlled for the 
potential confound.  
The Effectiveness of Imagery Interventions on Cognition 
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(1) Memory  
(1a) Prospective Memory (PM). Three studies explored the effect of 
imagery on PM (i.e., a participant’s ability to remember to carry out intended actions 
in the future) (Grilli & McFarland, 2011; Potvin et al., 2011; Raskin et al., 2019). In 
Grilli and McFarland, a study of weak quality, PM was assessed by recording the 
number of identified PM tasks completed under two experimental conditions: ‘self-
imagining’ and ‘rote-rehearsal’. A large effect size was found in favour of self-
imagining (η2=.51). In Potvin et al., individuals receiving imagery-based rehabilitation 
sessions performed significantly higher on an assessment of PM posttreatment 
compared to baseline with medium-large effect (d=.77), unlike the control group 
(d=.27). Additionally, both self-reported (d=.63) and relative-reported (d=.80) PM 
failures were significantly lower post-treatment for the intervention group only. 
Similarly, in Raskin et al., participants improved on a measure of PM following only 
the active treatment (i.e., training and practice of visual imagery), not the control, and 
a large effect was found (d=1.52). At one-year follow-up, participants performance 
worsened compared to post-intervention scores (d=.46); however, performance 
remained superior to their baseline with large effect (d=1.01). Overall, imagery-based 
approaches had a medium-large effect on PM.  
(1b) Episodic Verbal Learning and Memory. Three studies explored 
the use of imagery on episodic verbal learning and memory (Chiaravalloti et al., 2016; 
Grilli & Glisky, 2010; Grilli & Glisky, 2011). In Chiaravalloti et al., two 
neuropsychological assessments assessed participants immediate and delayed recall of 
a piece of prose (e.g., a story or list of words). On one assessment, the treatment group 
demonstrated significant improvements compared to the control post-treatment with 
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medium effect (η2=.064). 49% of the treatment group showed greater than a 10% 
improvement versus 18% of the control, and the two groups performed similarly 
again at 6-month follow-up regardless of whether they attended booster sessions. 
However, on the second measure, a non-significant and negligible effect was noted in 
the treatment group post-intervention (η2=.001). In Grilli and Glisky (2010), a study 
of weak quality, memory was assessed by recording the proportion of correctly 
recognised sentences under three different encoding conditions (outlined in Table 3: 
‘self-imagining’, ‘structural baseline’ and ‘semantic processing’). Self-imagining led to 
significantly higher performance than semantic processing with large effect (η2=.71), 
which in turn led to higher performance than the structural baseline condition with 
large effect (η2=.27). Likewise, in Grilli and Glisky (2011), a study of weak quality, 
memory was assessed by recording the proportion of correctly recalled word pairs 
under four different encoding conditions (outlined in Table 3: ‘self-imagining’, ‘other 
person imagining’, ‘visual imagery’ and ‘semantic elaboration’). Self-imagining again 
enhanced cued recall significantly more than: (1) visual imagery, with large effect 
(η2=.43); (2) semantic elaboration with large effect (η2=.30), and (3) other imagining 
with large effect (η2=.55). However, regardless of encoding condition, performance 
declined across the retention period. Based on these findings, imagery strategies 
enhance verbal learning and memory with a medium-large effect; however, two of the 
three studies are low in quality and the remaining study reports mixed findings. 
(1c) ‘Everyday’ Memory. Two studies looked at participants’ ability to 
remember everyday things such as a name or face (Boccia et al., 2019; Chiaravalloti et 
al., 2016). In Boccia et al., the participants performance improved posttreatment, 
falling within the expected range when compared to a normative sample. In 
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Chiaravalloti et al., the treatment group demonstrated significantly greater 
improvement compared to the control, and a medium effect was evident (Cohen’s 
w=.43).  
(2) Navigational and Visuospatial Abilities 
Boccia et al. (2019), a study of moderate quality, tested the effect of imagery on 
navigational and visuospatial abilities. All baseline scores indicated significant 
impairment compared to a non-BI normative sample and intervention effects were 
examined by comparing post-treatment scores to the same normative sample (ES has 
therefore not been computed). On two standardised tasks assessing navigational skills 
posttreatment, the participant did not significantly differ from norms for learning (i.e., 
immediate recall); however, treatment effects were maintained at follow-up for only 
one of the two tasks. In terms of delayed recall, performance significantly differed 
from norms in one of the two tasks posttreatment, though performance in both tasks 
was non-significant at follow-up. In an ecologically valid map-following task, 
performance was errorless posttreatment and at eight-month follow-up, 
demonstrating 100% effectiveness compared to 75% effectiveness pre-treatment. 
Similarly, on two tasks assessing visuospatial skills, no significant difference was found 
between the participant’s performance and normative data immediately 
posttreatment or at follow-up. Findings therefore indicate that imagery-based 
treatments can lead to improvements in navigational and visuospatial abilities, which 
are largely maintained at follow-up. However, this is based on a single case-study and 
should be interpreted cautiously. 
 
The Effectiveness of Imagery Interventions on Mood 
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(1) Anxiety and Depression 
Two studies explored the effect of imagery on anxiety and depression 
(Chiaravalloti et al., 2016; Potvin et al., 2011). Chiaravalloti et al., a study of strong 
quality, utilised a behavioural intervention that teaches context and imagery to 
facilitate new learning. The authors reported no significant differences on anxiety 
between intervention and control groups posttreatment, and no effect of the imagery 
intervention was found (η2=.00). Similarly, following an imagery-based rehabilitation 
programme for PM, a study of moderate quality (Potvin et al., 2012), reported no 
significant main effects of Time (pre/post) or Group (treatment/control) on anxiety 
nor a significant interaction effect. However, within-group effects demonstrated a pre-
post reduction in anxiety for the intervention group only (d=.54).  
For depression, Chiaravalloti et al. found no significant differences between 
treatment and control groups pre- to post-intervention and no effect of the imagery 
intervention was found (η2=.00). It is not possible to calculate pre-post ES by group. 
In Potvin et al., reductions in depression were large for the intervention group (d=.86) 
and small for the control group (d=.25).  
The non-significant results reported in Potvin et al., despite medium-large ES, 
may be due to the small sample size in the treatment group (n=10) resulting in 
inadequate power to show significance (Type II error). Nevertheless, findings conflict 
between the two studies, likely due to vast differences between the interventions and 
outcome measures utilised.  
(2) Self-compassion, Relaxation, and Empathy 
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Campbell et al. (2019) and O’Neill and McMillan (2012), studies of moderate 
quality, explored the effect of CFI and RI on self-compassion, relaxation levels and 
empathy. The studies compared the effects of CFI and RI as well as exploring their 
combined effect, thought to represent the general effect of imagery. They differed in 
that O’Neill and McMillan selectively recruited individuals with low empathy at 
baseline.  
In Campbell et al. (2019), post-treatment self-compassion scores did not 
significantly differ between groups, but a small ES was reported in favour of RI 
(d=.28). Combined, the interventions did not lead to a significant change in self-
compassion (d=.03, small effect). ES cannot be computed for O’Neill and McMillan 
(2012); however, post-treatment self-compassion scores did not significantly differ 
within or between groups.  
Examining relaxation as the outcome, Campbell et al. (2019) found no 
significant differences between groups posttreatment, reporting a small ES in favour of 
RI (d=.15). However, pre-post treatment effects demonstrated improvement in 
relaxation levels with large effect for the CFI group (d=1.00) and small effect for the 
RI group (d=.36) due heightened baseline scores. Examining the combined effect of 
RI and CFI, relaxation scores significantly improved over time (d=.67, medium-large 
effect). In O’Neill and McMillan (2012), post-test relaxation scores did not 
significantly differ within or across groups with a small ES found in favour of RI 
(d=.38).  
For empathy, Campbell et al. (2019) reported no significant differences 
between groups posttreatment, and a small effect was shown in favour of RI (d=.32). 
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When groups were pooled, the authors reported a non-significant trend towards 
increased empathy posttreatment with small-medium effect (d=.35). Pre-post 
calculations indicate that CFI increased empathy posttreatment with small effect 
(d=.17) and RI with medium-large effect (d=.60). In O’Neill and McMillan, no 
significant differences in posttreatment empathy scores were reported between the two 
groups. When the groups were combined, a small effect of imagery intervention was 
found on empathy (d=.32). Analysed independently, a medium-large yet non-
significant effect was found of CFI on empathy (d=.71) and a negligible effect of RI 
was reported (d=.05).  
Despite non-significant results, medium-large ES suggest that imagery 
approaches can enhance levels of relaxation and empathy; though, it is difficult to 
establish superiority of CFI over RI due to conflicting results between the two studies. 
It appears less likely that imagery influences self-compassion. However, the authors 
question whether the outcome measures used were sufficiently sensitive to detect 
changes within a single session. 
(3) Quality of Life (QoL) 
Raskin et al. (2019), a study of strong quality, explored the use of a PM 
rehabilitation programme on QoL. The authors reported no significant pre-post 
differences in QoL in the intervention group, though, a medium ES was found 
(d=.62). 
The Effectiveness of Imagery Interventions on Behaviour 
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One study (Chiaravalloti et al., 2016) examined the impact of imagery on 
disinhibited behaviour. Informant reported improvements in disinhibition were noted 
in the treatment but not the control group, and a medium ES was found (η2=.046). 
No significant differences were found on self-report measures of disinhibited 
behaviour for either group. 
Discussion 
This paper aimed to systematically review the use of imagery-based 
approaches on psychological outcomes (i.e., cognition, mood and/or behaviour) for 
adults who have an ABI. Nine eligible papers were reviewed, predominantly including 
participants who had experienced a moderate to severe TBI following a fall, RTA or 
assault, and a male majority was found in all studies. Across studies, participants were 
widely found to have impaired cognitive functioning in domains such as memory, 
attention, visuospatial and executive abilities when compared to non-ABI normative 
samples at baseline. 
It is therefore unsurprising that seven of the nine papers explored the use of 
various imagery-based strategies on cognition. Six studies investigated new learning 
and memory, encouraging participants to use strategies such as imagining themselves 
completing a future task with as much sensory detail as possible; and one study looked 
at post-injury navigational and visuospatial abilities, teaching a participant to generate 
and retrieve mental images of navigational representations. The remaining two studies 
explored the effect of compassion- and relaxation-based imagery exercises (e.g., the 
‘compassionate calm self’ or ‘special relaxing place’) on mood outcomes of relaxation, 
empathy, and self-compassion. No studies specifically targeted behaviour with their 
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intervention, with only one study examining disinhibited behaviour as a secondary 
outcome pre- and post-treatment. 
Summary of Main findings  
(1) Cognitive Outcomes 
Of all the DVs included in the reviewed studies, memory was the most 
common outcome and underwent the biggest post-treatment change when compared 
to comparator or control groups. For example, imagery yielded medium-large ES on 
prospective memory (PM) across three studies, ranging in quality from weak to strong 
(Grilli & McFarland, 2011; Potvin et al., 2011; Raskin et al., 2019). Likewise, imagery 
strategies were found to have a medium-large effect on episodic verbal learning and 
memory, which improved posttreatment in three studies (Chiaravalloti et al., 2016; 
Grilli & Glisky, 2010; Grilli & Glisky, 2011); though, two of the three studies are low 
in quality and uncontrolled. In two studies, imagery also led to enhanced memory for 
everyday things (e.g., names and faces) when compared to neuropsychological norms 
or a control group post-treatment (Boccia et al., 2019; Chiaravalloti et al., 2016). 
However, Boccia et al. did not report ES so standardised comparisons cannot be 
made across the two papers. Promising results were also reported for imagery as a 
treatment for navigational and visuospatial impairments (Boccia et al., 2019); 
although, findings are tentative and based on a single case study that produced no ES. 
Overall, findings suggest that imagery is effective when used as a cognitive 
intervention with ABI samples; however, this conclusion is tentative due to limitations 
in study designs and possible confounding variables. For example, since the same 
participants were included in multiple studies (Grilli & Glisky, 2010; Grilli & Glisky, 
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2011), it is possible that results may reflect a pre-existing idiosyncrasy of the 
participant sample.  
(2) Mood Outcomes 
When compared to a control group receiving a brief psychoeducational 
intervention, one study (Potvin et al., 2011) reported non-significant reductions in 
anxiety and depression post imagery intervention with medium-large effect. However, 
another reported no effect of an imagery intervention on either anxiety or depression 
when compared to a control (Chiaravalloti et al., 2016). Conflicting results may be 
due to differences between the outcomes and treatments used in the two studies. That 
is, Chiaravalloti et al. used a behavioural intervention in attempt to improve 
participant’s encoding and recall of a piece of prose, whereas Potvin et al. utilised 
individual rehabilitation sessions that focused on PM functioning. Moreover, as both 
interventions primarily aimed to restore cognitive function, changes in mood are 
arguably secondary to (and less likely than) those in memory. Further research would 
therefore be helpful in establishing the impact of appropriate imagery-based 
treatments that specifically target anxiety and depression following ABI.  
For the DV of relaxation, two studies found no significant differences pre to 
post CFI or RI intervention. When data for both groups were combined (i.e., when 
data for the RI and CFI groups were analysed together), a medium-large effect of 
imagery intervention was reported in one study (Campbell et al, 2019). However, data 
were not available to calculate ES for O’Neill & McMillan (2012) and direct 
comparison was therefore not possible. In terms of empathy, imagery-based 
interventions did not result in significant changes post-treatment; however, effects 
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were inconsistent across the two studies. Campbell et al. reported large pre-post effects 
of RI on empathy (and greater than CFI), whereas in O’Neill and McMillan the 
reverse was shown. Notably, in O’Neill and McMillan, participants scored at least one 
standard deviation below the general population mean for empathy at baseline, which 
was not the case for Campbell et al. Hence, it is possible that pre-existing differences 
in participant levels of empathy modulated the effectiveness of the interventions (i.e., it 
may be that individuals with low empathy levels at baseline are more responsive to 
CFI than RI). Neither of the two studies found an effect of either imagery intervention 
on self-compassion posttreatment.  
Finally, only one study explored the effect of imagery on QoL (Raskin et al., 
2019). When compared to a control group who received PM training without 
imagery, a non-significant improvement in QoL was found in the intervention group 
with medium effect; though, further research is needed to confirm findings.  
(3) Behaviour Outcomes 
Behaviour was only examined in one study (Chiaravalloti et al., 2019). 
Informant-reported improvements in disinhibited behaviour were evident for the 
treatment but not the control group, and a medium ES was found. Self-report 
measures did not support this finding; hence, results are promising yet conflicting and 
limited to one study. Overall, the evidence-base for the use of imagery interventions 
for both psychological wellbeing and behaviour in ABI is extremely limited. 
Findings in Relation to Previous Evidence 
In the present review, imagery was found to have significant medium-large 
effects on cognition, particularly memory. No published reviews have specifically 
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examined the effects of imagery on cognitive outcomes following brain injury; though, 
a systematic review by O'Neil-Pirozzi, Kennedy and Sohlberg (2016) examined the 
use of internal memory strategies (69% of which included visual imagery) on memory 
and new learning post-ABI. The authors report that in 90% of the 46 reviewed 
studies, post-intervention improvement or positive change was found on at least one 
cognitive outcome measure (e.g., the California Verbal Learning Test and Wechsler Memory 
Scales), offering tentative support for the current findings. However, for several reasons 
it is not possible to make standardised comparisons to the findings of the present 
review. Firstly, O’Neil-Pirozzi et al. do not report ES; and secondly, within their 
analysis, they did not separate studies that used imagery interventions from those 
using other forms of internal memory strategies. 
In the current review the effect of imagery on mood and wellbeing was 
variable across studies and often did not reach significance, despite some studies 
reporting medium-large ES (likely due to small sample sizes). No previously published 
reviews selectively explore the use of imagery on mood within ABI groups. However, 
contrary to the present review, reviews have demonstrated significant improvements 
in QoL and reductions in symptoms of depression and anxiety post imagery 
intervention in adults with long-term health conditions (e.g., Giacobbi et al., 2015). 
The RCTs reviewed by Giacobbi et al. found that guided-imagery also led to a 
reduction in pain (Baird et al., 2010; Baird & Sands, 2004; Fors et al., 2002; Fors & 
Gotestamm, 2000; Lewandowski, 2004), increased self-efficacy in managing pain and 
disease-related symptoms (Menzies et al., 2006), as well as improved psychological 
wellbeing (Baird & Sands, 2004; Menzies et al., 2006). Furthermore, a meta-analysis 
by Morina et al. (2017) found that in adults living with various mental health 
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diagnoses, imagery rescripting reduced symptoms of PTSD (Hedges-g = 1.48) and 
social anxiety disorder (g = 1.25) with large effect, and depression with medium-large 
effect (g = .61). Such findings suggest that exploration of imagery-based approaches 
within ABI is likely to be worthwhile. However, Morina et al. note review limitations 
including a general scarcity of research, as well as small sample sizes and poor study 
design in the included papers (studies were predominantly of low quality and 
uncontrolled). As in the present review, findings should therefore be interpreted 
cautiously. 
This review found no effect of an imagery intervention on self-reported 
disinhibited behaviour, and a medium effect of imagery on informant-reported 
disinhibited behaviour. No published reviews have specifically examined the effect of 
imagery-based approaches on disinhibited behaviour in ABI nor non-ABI 
populations; hence findings cannot be directly compared. However, a meta-analysis 
(n=1528) looking at ‘mental contrasting’ for improving health related behaviour in 
non-ABI groups was conducted by Cross and Sheffield (2017). Mental contrasting 
involves imagining a desired future and contrasting it with the present circumstances, 
prompting an individual to realise that action is required to achieve their preferred 
reality. The imagery-based approach was found to have a significant yet small effect 
on health behaviours at four weeks (g = 0.28) and an increased effect at up to three 
months (g = 0.38). Alternatively, within ABI groups, systematic reviews exploring 
behavioural outcomes largely focus on the use of pharmacological rather than 
imagery-based treatments (e.g., Ter Mors et al., 2018; Nash et al., 2019). For 
example, Ter Mors et al. examined the use of Amantadine, a widely used clinical 
treatment for behaviours that challenge (e.g., agitation and aggression). Of the 11 
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reviewed papers, two RCT’s and three case-studies indicated a reduction in target 
behaviours post-intervention; however, results were inconsistent. The authors 
therefore stated that further research suitable for the heterogeneous ABI population 
(e.g., randomised SCEDs) is necessary in determining effective approaches to 
behaviour management post-injury. 
Limitations of the Reviewed Studies 
The search strategy and application of inclusion criteria produced nine 
empirical papers that supported this review’s aims. Considering the broad definition 
of imagery used in the review, in addition to the intentional inclusion of multiple 
outcomes, a key observation is just how little research has examined the potential of 
imagery for people with ABI. Nonetheless, it is in line with previous systematic reviews 
conducted within the ABI population that look at outcomes of cognition, mood, and 
behaviour. For example, in a review of cognitive, emotional, and behavioural care 
needs of people with TBI, only three studies were included (Jennekens, De Casterlé & 
Dobbels, 2010); six studies were included in a review of non-pharmacological 
treatments for depression post-TBI (Gertler et al., 2015), and three were included by 
Knapp et al. (2017) when exploring multiple interventions for post-stroke anxiety. 
Unlike the present review, inclusion criteria for these reviews specified that papers 
must describe randomised studies with adequate control. Instead, for the purposes of 
this review, grey literature and dissertations were not examined and only studies 
published in peer-reviewed journals were included. Hence, although not all relevant 
research was sought, the identified studies were of an acceptable standard to answer 
the research question.  
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 Only one study used an RCT design (Chiaravalloti et al., 2016). The study 
outlined relatively good retention, low drop-out and encouraging initial outcomes in 
everyday memory, showing promise for future research. However, the small sample 
size within the booster group (n=17) is limiting when examining long-term treatment 
effects. Therefore, it is recommended that further research includes sufficient follow-
up periods and multi-centre RCTs to achieve adequate sample sizes and power. 
Sample size was also reported as a limitation in four further studies (Boccia et al., 
2019; Campbell et al., 2019; Potvin et al., 2011; Raskin et al., 2019). It is suggested 
that studies with small sample sizes (Slavin & Smith, 2009) and of low quality (A-Tjak 
et al., 2015) tend to report larger ES; hence, it is possible that treatment effects could 
be overestimated in these studies.  
 Except for Boccia et al., ES were provided by or calculated for all papers; 
however, for two studies, it was not possible to calculate all within-group pre-post 
effects due to limited reported data (Chiaravalloti et al., 2019; O’Neill & McMillan, 
2012). ES was reported in terms of eta squared (η2) for three studies (Grilli & Glisky, 
2010; Grilli & Glisky 2011; Grilli & McFarland, 2011), partial η2 for one study (η2p: 
Chiaravalloti et al., 2019), Cohen’s d for three studies (Campbell et al., 2019; O’Neill 
& McMillan, 2012; Raskin et al., 2019) and a mixture of the Cohen’s d and η2 for one 
study (Potvin et al., 2011). Reporting η2p is preferable to η2 when comparing studies 
(Cohen 1973; Richardson, 2011) due to η2p partialling out the effects of other 
independent variables. However, when mixed ANOVAs are used, such as in Potvin et 
al., the classification of a large ES is less conservative for η2p (Levine & Hullett, 2002); 
thus, the use of η2 minimises the chance of overestimating the treatment effect. 
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 A further limitation of the evidence is the inadequate use of control groups in 
most studies, with only three of the nine studies using an ABI control (Chiravallotti et 
al., 2016; Potvin et al., 2011; Raskin et al., 2019). The use of a control group was 
noted as problematic in Potvin et al., in which the authors report that the intervention 
was “probably” efficacious as the frequency and the intensity of the control and the 
treatment condition were not equivalent (Sohlberg & Mateer, 2001). They therefore 
suggested that that visual imagery techniques should be compared to an equivalent 
intervention in future studies. Five of the included studies attempted to do this by 
using comparator conditions (Campbell et al., 2019; Grilli & Glisky, 2010; Grilli & 
Glisky, 2011; Grilli & McFarland, 2011; O’Neill & McMillan, 2012). Boccia et al. did 
not use a control/comparator and consequently recommended that study findings 
should be interpreted with caution. The authors suggest that further investigations of 
imagery-based rehabilitation for spatial navigation and memory, particularly by 
means of RCTs, are needed to draw definite conclusions.  
 Furthermore, only three studies used a follow-up period (Boccia et al., 2019; 
Chiaravalloti et al., 2016; Raskin et al., 2019), ranging from 6 to 12 months. Whilst it 
is promising that no significant deterioration was noted on any measure between post-
treatment and follow-up, six of the nine included papers failed to follow participants 
up at all; thus, it is impossible to know whether treatment effects were maintained. 
This is especially problematic as delayed treatment effects have been shown within 
ABI groups, suggesting that it can take up to six months post-intervention for a 
treatment effect to emerge (Hsieh et al., 2012). 
 Most studies in this review were classified as Weak or Moderate, suggesting that 
further research of higher quality is needed to confirm current findings. However, it is 
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possible that the quality tool used could have underrated quality due to strict marking 
of certain categories. For example, despite a 94% retention rate being reported by 
Grilli and Glisky (2010), they were rated Weak on the withdrawal and dropout 
category due to failing to report the reasons associated with participant withdrawals. 
Overall, quality ratings indicated that the study design, blinding and data collection 
methods were key areas of weakness for many studies; it is therefore recommended 
that these are considered in future research.  
Limitations of this Review 
Although PROSPERO was searched to ensure that no previous papers had 
reviewed imagery use in ABI, it is worth noting that prior to conducting the present 
review, it was not pre-registered. It is also notable that the conclusions of this review 
are based only on published studies. Therefore, publication bias, whereby studies with 
significant results or effects are more likely to be published, may mean that review 
findings show a skewed, overestimated perception of imagery effectiveness. Further 
bias could have also been introduced through the use of only one reviewer and future 
reviews should aim for a minimum of two reviewers when assessing study eligibility 
and quality.  
A further limitation is the broad nature of the review question and inclusion 
criteria. Across studies, the application of imagery is markedly different; hence, it 
difficult to compare studies and establish overall effectiveness. Additionally, although 
multiple outcomes were intentionally included, their varied nature further impacts on 
the comparison of findings. However, at present, research into imagery use within 
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ABI groups is sparse and more specific reviews are unlikely to yield enough papers to 
draw definitive conclusions.  
For reasons outlined above, it was not valid to combine ES across studies to 
produce an overall estimated effect of imagery-based approaches within ABI, and 
meta-analyses could not be conducted. Due to the small number of studies included 
and their heterogeneous nature, it is also difficult to establish superiority of specific 
interventions. Nevertheless, the effects of imagery interventions on psychological 
outcomes for adults with ABI were reviewed, answering the review question with the 
conclusions outlined below. 
Conclusions and Recommendations 
Imagery-based interventions had a medium-large effect on cognitive 
functioning, particularly memory, including participants ability to remember planned 
future events/tasks and to learn new information. Navigational and visuospatial 
abilities were also improved post imagery treatment, though ES cannot be calculated. 
The effect of imagery on mood was variable across studies and did not often reach 
significance, despite some studies reporting medium-large ES on anxiety, depression, 
and levels of relaxation and empathy. This may be due to small sample sizes and 
studies being underpowered in addition to variation in how these constructs were 
measured. Finally, some improvements in disinhibited behaviour were noted following 
imagery with medium effect; however, results were mixed and limited to only one 
study. 
Overall, this review tentatively suggests that imagery is an effective way of 
working psychologically with ABI groups. However, research exploring its use in 
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wider ABI populations (e.g., post-stroke) is lacking. Additionally, it would be beneficial 
to further explore the use of imagery interventions that target mood and behaviour 
related outcomes, which is exceptionally sparse within ABI despite promising findings 
in non-ABI populations. Multi-centre RCTs or randomised SCEDs are 


























Chapter III: A Values-based Intervention for Neurorehabilitation 




Psychological distress following an acquired brain injury (ABI) is often more 
debilitating than the physical and cognitive sequalae. It impacts negatively on long-
term functional and rehabilitative outcomes including social and occupational 
functioning, quality of life, and adjustment to the injury and its consequences. 
Emerging research suggests that Acceptance and Commitment Therapy (ACT) can 
help to improve mood and psychological adjustment post-ABI. However, depression 
is often associated with a negative bias in future thinking and may reduce motivation 
for engaging in valued-based activities. Imagery is shown to be an effective way of 
offsetting the impact of this negative bias in non-ABI groups. The current study 
therefore examined the use of a values-based intervention for inpatients with ABI and 
depression. Mental imagery was optional and added to the intervention for instances 
where participants demonstrated reduced motivation to engage in values-based 
activities. A multiple-baseline design (MBD) was used. Treatment response within and 
across participants (N=4) was evaluated through visual and TAU-U analysis of visual 
analogue scale (VAS) data. Standardised measures validated for an ABI population 
were administered pre- (T1) and post-baseline (T2), post-intervention (T3) and at two-
week follow-up (T4) and assessed using reliable and clinically significant change 
analysis. Findings for depression were the most improved after therapy, however 
findings conflicted across measures and were not always maintained at T4. Values-
based behaviour increased for all participants across the course of therapy. Quality of 
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life and adjustment reliably improved for less than half of the participants. Participants 
were highly motivated and experienced a positive bias in future thinking at baseline. 
The intervention was feasible and deemed acceptable by all participants. The 
























The UK Acquired Brain Injury Forum (UKABIF, 2019) reported that in the 
UK alone 1.3 million people live with the effects of brain injury at a yearly economic 
cost of fifteen billion (approximately 10% of the annual NHS budget) due to the 
increased health and social care input, lost work contributions and continuing disability. 
In 2016/17, this equated to 348,453 new hospital admissions due to an Acquired Brain 
Injury (ABI); that is, 954 admissions per day or one ABI-related admission every 90 
seconds (Headway, 2019). Furthermore, these figures are rising, with a 10% increase in 
admissions taking place between 2005 and 2017 (Headway, 2019). Psychological 
distress, such as depression, is common following ABI (Juengst, Kumar & Wagner, 
2017), with researchers arguing that it is often more debilitating than the physical and 
cognitive sequalae (Bertisch et al., 2013; Lishman, 1973). It is reported to impact 
negatively on long-term functional and rehabilitative outcomes (Cullen et al., 2018) 
including social and occupational functioning (Daniel et al., 2009; Mateer & Sira, 2006), 
quality of life (Bryant et al, 2010) and psychological adjustment to the injury and its 
consequences (Schönberger et al., 2014). Supporting individuals to adjust 
psychologically is therefore likely to aid recovery and make rehabilitation more 
beneficial (Whiting et al., 2012). 
To date, Cognitive Behavioural Therapy (CBT) is the most heavily researched 
psychological intervention within ABI groups. However, interventions often aim to 
ameliorate mental health symptomology that is disorder specific (e.g., targeting 
specific symptoms of anxiety and depression) and the reported effectiveness of CBT 
differs across studies. Whilst researchers have demonstrated post-CBT reductions in 
depression (Bradbury et al., 2008), anxiety (Hsieh et al., 2012), seizure-related panic 
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attacks (Gracey, Oldham & Kritzinger, 2007), Obsessive Compulsive Disorder (OCD; 
Williams, Evans & Fleminger, 2003) and Post Traumatic Stress Disorder (PTSD; 
Bryant, Moulds, Guthrie & Nixon, 2003), others have reported mixed results (e.g., 
Anson & Ponsford, 2006; Hodgson et al., 2005) or found CBT to be no more effective 
than control groups or treatment as usual (e.g., Backhaus et al., 2016; Fann et al., 
2015; Ashman et al., 2014; Lincoln & Flannaghan, 2003). This not only makes it 
difficult to interpret findings, but the question remains whether CBT, particularly the 
cognitive component, is suited to the ABI population (Whiting et al., 2012). For 
instance, it is suggested that cognitive restructuring is not accessible to some 
individuals due to the presence of cognitive deficits such as inflexibility and executive 
functioning difficulties (Blanchet, Paradis-Giroux, Pepin & Mckerral, 2009; Hodgson 
et al., 2005). Additionally, it is argued that thought challenging is inappropriate for 
realistic thoughts centred around post-ABI circumstances (Graham et al., 2015; 
Kangas & McDonald, 2011). 
 Instead, emerging research demonstrates promising outcomes for third wave 
approaches such as Acceptance and Commitment Therapy (ACT; Hayes, Luoma, 
Masuda & Lillis, 2006). ACT is a transdiagnostic, action-oriented approach that aims 
to increase psychological flexibility through six core processes: (1) acceptance, 
referring to noticing unpleasant or unwanted internal experiences, without attempting 
to change or avoid them; (2) cognitive defusion, involving changing the way an 
individual interacts or relates to their internal experiences, distancing themselves from 
their thoughts and viewing them as passing events; (3) being present, which promotes 
an ongoing and non-judgemental awareness of the here and now; (4) self-as-context, 
allowing individuals to connect with a sense of self that is not defined by certain 
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internal events but is rather a context in which those events occur; (5) values 
identification, which encourages the individual to connect with what truly matters to 
them; and (6) committed action, the process of committing to actions that are value-
consistent, even in the presence of difficult internal experiences. Individuals are 
therefore supported to function in the face of difficulty and distress, which is 
considered a normal part of the human experience (Hayes, 2004); however, whilst 
reducing distress is not the primary aim of ACT, this can occur as functionality 
improves (Hayes et al., 2006).  
The principles of ACT arguably fit well within neurorehabilitation, which 
aims to minimise disability and optimise recovery by supporting individuals to work 
towards personalised therapeutic goals to rebuild a life that is meaningful to them 
(Turner-Stokes et al., 2005). In fact, some of the key principles in ACT are 
inadvertently utilised in the context of certain neurorehabilitation programmes. For 
instance, the metaphoric identity mapping (MIM) model (Ylvisaker, McPherson, 
Kayes & Pellet, 2008) draws upon several core ACT processes including, but not 
limited to, valued goals and committed action. It aims to facilitate identity 
reconstruction, goal-setting and re-engagement for individuals who have sustained a 
Traumatic Brain Injury (TBI) by: (1) encouraging the individual to think about the 
‘actual-self’ versus the ‘possible/hoped-for-self’; and (2) setting realistic goals that 
support the individual in living a meaningful life post-injury. Furthermore, elements 
routinely used within ACT such as metaphors or analogies (Hayes, 2004) are often 
utilised within ABI groups due to their ability to make difficult-to-understand and 
abstract concepts accessible (Whiting et al., 2017; Ylvisaker et al., 2008). Nonetheless, 
although several authors have recommended the direct use of ACT in the ABI 
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population (e.g., Whiting et al., 2012; Soo, Tate & Lane-Brown, 2011; Kangas & 
McDonald, 2011), the evidence-base remains in its infancy.  
 Two published studies have specifically explored the use of ACT within 
neurorehabilitation. Firstly, Whiting et al. (2019) conducted a pilot-RCT that 
compared a six-week ACT group-based therapy to an inactive control (Befriending 
Therapy) for adults with a diagnosed TBI. Pre-intervention, all participants met the 
clinical threshold for psychological distress on the Hospital Anxiety and Depression Scale 
(HADS-21) or the Depression Anxiety and Stress Scale (DASS-9). Post-intervention, 
significant reductions in symptoms of depression and stress were evident in the ACT 
group when compared to the control. Such reductions were hypothesised by the 
authors to have been largely achieved via the values and committed action 
components of ACT, which rely less on cognitive ability. However, despite mood 
improvements, no significant changes were evident in the primary outcomes of values-
consistent living and psychological flexibility. This was thought by the authors to be 
due to the small sample size (n=19) and the fact that the study was unpowered. 
Therefore, to achieve the desired recruitment, it was recommended that future studies 
deliver ACT in a one-to-one format.  
In the second study, Whiting et al. (2017) explored the effectiveness of a seven-
session manualised intervention for two participants with severe TBIs using an 
uncontrolled pre-post design. For one participant reliable and clinical improvements 
were found on measures of mood, psychological flexibility and quality of life post-
intervention, in addition to improvements in values-based living. Similarly, the second 
participant demonstrated a reduction in negative affect and an increase in values-
based behaviour post-treatment. However, measures of committed action did not 
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reliably change for either participant following the intervention. Similar results have 
been reported outside of the neurorehabilitation context, whereby participants with 
an ABI have experienced reductions in psychological distress with medium to large 
effect following ACT-based treatments (Majumdar & Morris, 2019; Sianturi et al., 
2018; Graham et al., 2015). However, limitations around study design persist in these 
studies, for instance, the lack of appropriate control groups. 
Despite a strong evidence-base supporting the use of psychosocial 
interventions for a diverse range of behavioural and mental health concerns, research 
frequently fails to address how interventions translate to clinical practice (Fairburn & 
Wilson, 2013), with therapists reporting that standardised manuals do not meet the 
needs of real-world clients and settings (Addis & Krasnow, 2000). Instead, 
modularised treatments can allow for a personalised approach whist remaining 
grounded in theory and evidence. ACT arguably lends itself well to modularisation 
with its transdiagnostic approach guiding case formulation and allowing for the 
flexible selection of therapy tasks from the six complementary treatment components 
outlined above. Outside of the ABI population, Villate et al. (2016) examined a 
modular approach to ACT with 15 adults who were experiencing clinically significant 
psychological distress (predominantly anxiety and depression). Participants were 
randomly allocated to one of two ACT modules: the ACT OPEN module, consisting 
of procedures that targeted the acceptance and cognitive defusion processes of the 
psychological flexibility model; and the ACT ENGAGED module that only targeted 
the values and committed change processes of the model. According to self-reported 
feedback, both interventions were deemed acceptable by all participants, with no 
dropouts nor missed sessions in either module. Additionally, both groups 
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demonstrated significant improvements in symptom severity and quality of life; 
however, whilst the ACT ENGAGED group experienced a smaller effect on 
symptoms than those allocated to the ACT OPEN module, they reported greater 
quality of life improvements.  
In light of the above, the emerging evidence-base for ACT suggests that, 
despite design limitations, it can be useful when working psychologically with ABI 
groups. In particular, researchers advocate for the use of the ‘behavioural’ 
components of ACT (i.e., values and committed action) within neurorehabilitation 
(e.g., p.67, Soo et al., 2011). Values are purposefully chosen life directions that guide 
individuals to live meaningful and fulfilling lives (Hayes et al., 2006); for example, an 
individual may have a value of friendliness or of feeling connected to others. A value is 
therefore not something that can be reached (i.e., friendliness is not an endpoint, 
feeling connected to others is not something that can be achieved and ‘ticked off’), but 
something that an individual can continue to work in a direction towards throughout 
their life. Nonetheless, setting goals that are value consistent (e.g., saying hello to a 
neighbour; having a weekly dinner with family) can encourage individuals to engage 
in concrete and meaningful behaviours, despite the consequences of their injuries 
(Kangas & McDonald, 2011). As values-based approaches and goals can be tailored to 
the individual’s personal desires, abilities, and circumstances, they are appropriate for 
use with heterogeneous populations (Hayes, 2004), such as ABI groups.  
Sharma (in prep) assessed the effects of the values and committed action 
components of ACT for six participants undergoing inpatient neurorehabilitation 
after an ABI. The intervention utilised values-based goal setting, allowing goals to be 
tailored to each individual and, if necessary, adapted over the course of therapy; thus, 
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ensuring that cognitive and/or physical limitations could be considered. Sharma 
found the intervention to be acceptable to all clients. Furthermore, all participants 
reported increased values-based behaviours post-intervention, with most participants 
also reporting reductions in symptoms of depression and heightened adjustment at the 
end of therapy. However, a key limitation was the use of broad inclusion criteria, 
which did not set any preconditions regarding psychological distress. This resulted in 
floor and ceiling effects for some clients. Furthermore, it is unclear whether the 
intervention would be acceptable, feasible, and beneficial for individuals with an ABI 
plus depression. 
In healthy populations, biases in cognitive-affective processes implicated in 
depression (e.g., lower positive and increased negative thoughts about the future) are 
central to its onset and maintenance (Matthews & MacLeod, 2005). This has led to 
the development of novel approaches that target these biases, with subsequent 
improvements in mood (e.g., Williams, Moore & Blackwell, 2015). Within ABI, 
Murphy et al. (2019) found that depressed mood is also characterised by a negative 
bias for imagining future events, which likely impacts on the successful 
implementation of a values-based intervention for this group. For example, an 
individual who perceives future events more negatively may be less motivated to 
engage in the values-based activities identified during therapy. In non-ABI groups, 
mental imagery is shown to be an effective way of offsetting the impact of this negative 
bias (e.g., Renner, Murphy, Ji, Manly & Holmes, 2019). 
 Mental imagery is defined as the ‘simulation or re-creation of perceptual 
experience across sensory modalities’ (Pearson et al., 2013). Neural substrates 
recruited during sensory perception are also activated during mental imagery (Pearson 
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& Kosslyn, 2015), suggesting that imagery can evoke the perceptual details of possible 
future events in addition to the experiential correlates of these experiences. An 
individual can therefore experience mental events as if they are real (Moulton & 
Kosslyn, 2009). For an individual to plan their behaviour, future cognition is key, with 
researchers indicating that imagery representations can induce powerful emotional 
responses at subjective, physiological, and neural levels (Ji, Heyes, MacLeod, & 
Holmes, 2016). Therefore, whilst mental representations that are perceived as 
negative may encourage avoidance (Moulton & Kosslyn, 2009), those perceived as 
enjoyable or fulfilling can increase approach behaviour (Renner, Ji, Pictet, Holmes, & 
Blackwell, 2017). This may be especially relevant in ABI when damage to key brain 
structures (e.g., executive prefrontal areas) is common and, in addition to depression, 
can lead to disruptions in future cognition (Pearson, Naselaris, Holmes, & Kosslyn, 
2015). 
Taking all of this into consideration, the current study was the first to examine 
the use of a values-based intervention for inpatients with ABI and symptoms of 
depression. For instances where participants demonstrated reduced motivation to 
engage in values-based activities, imagery was added. Given the novelty of the 
intervention, a single case experimental design (SCED) with baseline randomisation 
was chosen for cases to be studied individually and in detail, whilst maintaining a level 
of experimental control (Morely, 1996). The use of a SCED overcame some of the 
limitations of existing research in this area and allowed participants to act as their own 
control (Alderman & Wood, 2013), which is appropriate given the heterogeneity of 
the ABI population. The impact of the intervention was established using dependent 
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variables that measured meaningful behaviour, depression, quality of life, adjustment, 
and future thinking. 
 
Based on the previous research outlined above, the following hypotheses were 
proposed:  
1. The values-based intervention will increase values-based behaviour 
2. The values-based intervention will lead to lower levels of depression, improved quality of life 
and increased adjustment to brain injury 
3. The values-based intervention will decrease the negative bias in prospective cognition 
associated with depression 
Method 
Design 
A SCED was used in the form of a nonconcurrent randomised multiple-
baseline design (MBD). The design consisted of three stages (A-B + Follow-up), with 
the randomly selected baseline phase (A) lasting either two, three or four weeks. The 
intervention phase (B) consisted of five to seven sessions of a values-based therapy and 
was followed by a two-week follow-up period used to monitor outcomes once the 
intervention had been withdrawn. The effect of the intervention (the independent 
variable) was measured in several ways: Firstly, through standardised measures of 
each participants mood, quality of life, adjustment to brain injury and future thinking 
at pre- (T1) and post- (T2) baseline, immediately post-intervention (T3) and at follow-
up (T4); and secondly, via visual analogue scales (VAS) that examined participant 
mood and values-based behaviour throughout each of the three phases. Finally, the 
Values Bullseye was used as a process measure, recording how closely to their values 
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each participant perceived themselves to be living early in therapy, mid-way through 
therapy, post-therapy and at follow-up. 
Participants 
Ethical approval (see Appendices 1-2) was obtained to recruit participants 
from two London hospitals. In MBD, a minimum of three effect replications are 
required to demonstrate experimental control across participants, behaviours, or 
settings (Horner et al., 2005). However, a recruitment target of six participants was set 
for several reasons. Firstly, in attempt to meet the desired baseline power (0.8), 
whereby VAS data would need to be recorded at 18 timepoints per phase for a sample 
size of five (Shadish et al., 2014); and secondly, to allow for attrition. As depicted in 
Figure 2, four participants completed baseline and intervention phases, with three 
participants also completing follow-up. Previous SCEDs conducted within the ABI 
population have recruited a varied number of participants. For instance, studies have 
recruited from one (e.g., McKerracher, Powell & Oyebode, 2003; Lane-Brown & 
Tate, 2010) to three (e.g., Davies & Rofoth, 2010; Gertler & Tate, 2019), four (e.g., 
Jameison et al., 2017) or 11 participants (Ouellet & Morin, 2007). To maintain 
confidentiality, participants are referred to by their participant number throughout 
this paper. Further information relating to participant demographics can be found in 
Results (see Table 8).  
Figure 2  





For eligibility to be met, participants were required to be at least 18 years old 
and to have a diagnosed ABI. Additionally, participants needed to score above the 
cut-off for depression on the HADS (HADS-D>8), have an anticipated admission of 
at least 10 weeks (due to participation length), and to have sufficient verbal or non-
verbal communication and English language skills to understand and communicate 
information within sessions. Finally, they were required to have capacity to provide 
informed consent and the cognitive ability to engage in psychological therapy, as 
determined their psychology team. As the study examined a novel treatment, 
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participants were excluded if they presented with high levels of risk (i.e., substance 
misuse or suicidal intent or plans).  
 Initial assessments exploring psychological needs, capacity to consent, and risk 
were conducted by qualified psychologists within the service, as per normal practice. 
Individuals that met inclusion criteria were introduced to the study and, with consent, 
a meeting was arranged with the Chief Investigator (CI) in which detailed information 
about the study was provided using the Participant Information Sheet (PIS; Appendix 
3). Information was presented at a pace appropriate to each individual using strategies 
such as repetition, summaries, and images to support ABI related deficits. Various 
opportunities to ask questions were provided and clients were provided with a copy of 
the PIS. They were encouraged to take at least one day to consider whether they 
would like to participate, consulting trusted family, friends, or staff in making their 
decision. If a second meeting was set up, the CI ensured that clients remembered 
details of the study and reviewed key information before written informed consent was 
obtained (PCF; Appendix 4). All participants were recruited between October 2020 
and March 2021. 
Measures 
VAS Measures  
A template from the Association for Contextual Behavioural Science website 
(https://contextualscience.org/acbs) was adapted to generate vertical VAS measures 
that rated values-based behaviour and psychological distress on a scale of 0-10 
(Appendix 5). Although VAS can act as idiosyncratic measures that measure 
participant-specific symptomology, the included participants struggled to 
 90 
conceptualise their symptoms at the start of their participation. Therefore, the same 
scales were used across individuals. As VAS are sensitive over time, appropriate for 
daily testing and valid measures (when appropriately defined), they are considered 
appropriate for SCEDs (Klimek et al., 2017). VAS measures were administered as 
close to daily as possible in attempt to achieve adequate power (Shadish et al., 2014). 
Standardised Measures (T1, T2, T3, T4) 
The Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983), a 7-
item measure of anxiety and depression, scores each subscale from 0-21, with a cut-off 
score of eight for mild depression or anxiety (Zigmond & Snaith, 1983). In the present 
study, only depression scores were considered in accordance with the studies 
hypotheses. The HADS is deemed appropriate for inpatient settings and has been 
validated for use in the ABI population (Schönberger & Ponsford, 2010). It is reported 
to reduce the emphasis on common somatic symptoms experienced in long-term 
health conditions (e.g., fatigue); thus, enhancing the validity of measurement (Dahm, 
Wong & Ponsford, 2013). A meta-analysis by Bjelland et al. (2002) found the HADS 
test-retest reliability to range from adequate to excellent (.68 to .93). The internal 
consistency of the HADS-D was found to be excellent for depression within TBI 
(Cronbach’s α= .86; Schönberger & Ponsford, 2010) and post-stroke populations 
(Cronbach’s α= .85; Aben et al., 2002). 
 
The Quality of Life after Brain Injury (QOLIBRI; von Steinbüchel et al., 2010), a 
37-item measure, covers six QOL domains: Cognition, Self, Autonomy, Social, 
Emotions and Physical problems. In all domains, items are measured on a scale of 1 to 
5. Depending on item, 1 equates to “not at all satisfied” or “very bothered” and 5 
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equates to either “very satisfied” or “not at all bothered” (Appendix 6). Due to their 
applicability to the study hypotheses, only the Self and Emotions domains were used. 
Test-retest reliability and internal consistency is reported to be excellent for both the 
Self (ICC=.84, Cronbach’s α=.90) and Emotions (ICC=.78, Cronbach’s α=.88) 
domains. The QOLIBRI is validated in the ABI population in six languages (von 
Steinbuc̈hel et al., 2010). 
 
The Reactions to Impairment and Disability Inventory-Adjustment subscale (RIDI-A; 
Livneh & Antonak, 1990; Appendix 7), an eight-item measure, rates adjustment on a 
scale of 0 (“Never”) to 4 (“Often”). There is a maximum combined score of 32, with 
higher scores indicating increased adjustment. The RIDI is reported to hold good 
content and construct validity, and internal consistency (Cronbach’s α=.70 to .92; 
Livneh & Antonak, 1990). For the RIDI-Adjustment subscale, Cronbach’s alpha is .85 
(Livneh & Antonak, 1990).  
 
The Future Fluency Task (FFT; MacLeod et al., 1997; Appendix 8) measures 
biases in prospective cognition. Individuals are given one minute to generate as many 
likely or plausible self‐future experiences as possible for three time periods – next 
week, next year, and the next five to ten years. The total positive versus negative items 
are computed for each participant by summing across time periods. The FFT has 
been used within an ABI population (Murphy et al., 2019), though the reliability of 
the scale is not reported. 
Process Measure 
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The Bullseye Values Survey (BEVS; Lundgren, Luoma, Dahl, Strosahl & Melin, 
2012; Appendix 9), a visual analogue scale, was used to assess whether values-based 
behaviour altered throughout the intervention and follow-up phases. The BEVS is 
presented as a target with five circles on which participants rated how closely they 
perceived themselves to be living by their chosen value(s). The BEVS holds good test-
retest reliability (ICC=.85), correlating with measures such as the Subjective Well-
being Life Scale (r=.47).  
Measure of Acceptability 
The Client Satisfaction Questionnaire (CSQ; Larsen, Attkisson, Hargreaves & 
Nguyen, 1979; Appendix 10), a self-reported eight-item measure of service 
satisfaction, assessed the acceptability of the intervention. Each item is rated on a 4-
point scale, measuring areas such as the quality of the service, the extent to which it 
met participant needs and whether the service would be recommended to others. A 
single score of 8 to 32 is generated, with higher scores indicating greater satisfaction. 
The reliability and internal consistency of the scale is reported to be excellent 
(Cronbach’s α=.83 to .93; Attkisson, 2012). 
Procedure 
As outlined above, participation followed three broad stages (baseline, 
intervention, follow-up), the structure of which are outlined below.  
Baseline phase (A) 
Participants were randomly allocated to a baseline length of two-, three- or 
four-weeks using computer generated randomisation. Each participant completed 
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standardised measures prior to beginning their baseline period (T1), as well as daily 
VAS throughout. Three participants were supported by staff and caregivers to 
complete VAS due to memory, visual and physical impairments (Pt1, Pt2 and Pt4).  
Intervention phase (B) 
The intervention phase began immediately after baseline completion. 
Standardised measures were collected for the second time at the start of intervention 
(T2) and VAS were completed throughout. The Values Bullseye was completed on 
three occasions during the intervention phase – when values were initially established 
(sessions 1-2), mid-way through treatment (approximately session 4) and at the end of 
the intervention. Standardised measures were re-collected at the end of treatment 
(T3). 
Follow-up phase  
VAS continued throughout the two-week follow-up. Standardised measures 
and the Values Bullseye were completed for the final time at the end of the follow-up 
phase (T4). Participants were debriefed and all participants were asked to provide 
verbal and written feedback on their experience of the intervention (see Measures).  
Intervention  
The intervention was a values-based therapy, delivered by one of two 
therapists (therapist one, RA, or therapist two, SS; see Table 11). The original 
intervention protocol, co-created by authors JK and SS, was based on the ‘Values’ 
and ‘Committed Action’ components of Acceptance and Commitment Therapy 
(ACT; Hayes et al., 2006) and was developed using Villatte’s (2016) protocol. It was 
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adapted to include optional elements of imagery by JK and RA (see Appendix 11 for 
full protocol). The intervention was designed to support ABI related deficits using 
simplified information and metaphors, summary sheets, handouts, concrete examples, 
and the slower presentation of materials. Participants attended an average of six 
weekly one-hour sessions; however, shorter sessions (30-45 minutes) and more 
frequent sessions (twice weekly) were offered where necessary to suit individual needs 
and circumstances. The therapy comprised of three broad stages:  
(1) ‘Values clarification and reflection’: sessions covered the notion of values and 
participants were supported to consider their personal values before choosing 
one to three values of most importance to them. 
(2) ‘Goal-setting’: the therapist supported participants in generating goals aligned 
to their identified value(s). Where appropriate, imagery was used to guide 
participants in imagining themselves completing their identified goals, 
incorporating detailed sensory information. Goals were regularly reviewed 
throughout sessions and value-consistent behaviours were celebrated. 
(3) ‘Addressing obstacles’: participant-reported barriers to valued living were 
addressed. Chosen values were reviewed to ensure continued personal 
significance to the participant and, where necessary, goals were modified. 
Data Analysis  
Analysis of VAS Data  
VAS data relating to mood and meaningful behaviour was analysed in two 
ways: firstly, through visual analysis, and secondly, using TAU-U statistical analyses. 
Line graphs, the most common format of visual representation in SCED (Lane & 
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Gast, 2014), were used for the visual analysis of VAS data, providing an overall 
evaluation of the usefulness of the intervention (i.e., how reliable and consistent 
treatment effects appeared to be; Morley, 2015). However, as visual analysis can be 
subjective, criterion outlined by Kazdin (2019) was used to guide data evaluation (see 
Table 6). This criterion focuses on the proportion and rate of change within and 
across phases; thus, decreasing bias and ensuring the data analysis process is 
replicable.  
Table 6 
Kazdin’s (2019) Criterion for Evaluating Change in Visual Analysis 
 
Criterion Definition  
Change in central tendency 
(mean) 
The average score of data points across phases 
differs 
Change in trend A systematic increase or decrease in the 
trendline 
Shift in level  The pattern of the data changes between the 
last timepoint of one phase and the first 
timepoint of the next phase 
Non-overlap of data  The value of data points in one phase is not 
replicated in another 
 
For study hypotheses to be accepted, an increase or decrease was firstly 
necessary in the mean of the intervention phase when compared to baseline. The 
desired direction of change was dependent on the variable (i.e., mood or meaningful 
behaviour). Secondly, line graphs were expected to show an upward or downward 
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progression, or trend, of data in the intervention phase (Lane & Gast, 2014). To 
evidence clear treatment effects, baseline phases would have ideally outlined little 
variability in the data and either no trend or a trend in the opposite direction to the 
desired change (Kazdin, 2019). Less consideration was given to level in the analysis of 
data. As alterations in level focus only on the pattern of data during the end of one 
phase and start of the next, the overall pattern of data across phases is lost; hence, 
trend is considered more important (Gast & Spriggs, 2010). This was particularly 
pertinent in the present study, in which shifts in either variable were not expected on 
immediate commencement of the intervention. Instead, shifts were expected from 
approximately session two of the intervention onwards, following the initial 
introduction of values-based goal setting. Lastly, the overlap of data between phases 
was considered, with less overlap indicating a stronger effect of intervention. In 
summary, data with little variability that changes in means, levels, and trends, and 
that does not overlap between phases is indicative of reliable change.   
 Additionally, the use of a MBD allowed for comparison of effect across 
participants. For instance, if at week four of their participation, one participant was in 
their baseline phase and another participant was in week two of therapy, an effect 
would be expected only for the second participant as this is when the values-based 
therapy would likely influence their mood and/or behaviour. Due to the randomised 
baselines of two-, three-, and four-weeks, effects were therefore expected at either 
week four, five or six of participation. For causal evidence to be established, such 
effects had to be replicated a minimum of three times (Horner et al., 2005). Moderate 
to strong effects were required during visual analysis for effect size to be estimated 
(Kratchowill et al., 2010). 
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 Finally, TAU-U statistical analyses were conducted (Appendix 12). For a 
number of reasons, tau-analyses complement visual analysis: Firstly, it allows for 
increased objectivity and for small treatment effects to be detected (Morley, 2015); 
secondly, it controls for variability in baseline scores, allowing for increased accuracy 
when comparing between phases (Manolov, Perdices, Gast & Evans, 2014); and lastly, 
the proportion of overlap between phases can be assessed, whereby a TAU-U score 
equal to or close to one indicates no overlap, increasing confidence in causality of the 
intervention (Morley, 2015).  
Analysis of Standardised Data   
Standardised data was evaluated using analyses of reliable change (RC) and 
clinically significant change (CSC). RC differentiates change that is reliable in the 
statistical sense (i.e., change that is statistically significant) from change that could have 
occurred due to random fluctuation in measurement, for example, measurement error 
(Jacobson & Truax, 1991; Maassen, 2004). The Reliable Change Index (RCI) is equal 
to the individual’s pre-intervention score minus their post-intervention score divided 
by the measures standard error of difference (RCI=M1 – M2 / SEdiff). The standard 
error of difference is calculated using SEdiff = (√(2 x SEm2) and the standard error of 
mean is calculated using SEm=SD x √(1-r), with r referring to reliability. In the 
present study, the internal reliability of each measure was used (Morley, 2015) as 
outlined in Table 7. An RCI score greater than +/- 1.96 was required for RC to be 
met. 
Table 7 
Reliability and Normative Sample Statistics used to Calculate RC and CSC 
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Measure Reliability Statistic 
Cronbach’s alpha (α) 
Clinical Norms 
Mean (SD)  
Non-Clinical Norms 
Mean (SD) 
HADS-D .86 a 7.80 (4.90) a 3.68 (3.07) a 
QOLIBRI-
Self 
.90 b 60.03 (24.69) b - 
QOLIBRI-
Emotions 
.88 b 71.71 (24.69) b - 
RIDI .89 c 23.4 (5.3) d - 
Note. Non-clinical means are not available for the QOLIBRI or RIDI as these are 
disability specific measures. a Data from Schönberger and Ponsford (2010). b Data 
from Von Steinbüchel et al. (2010). c Reliability statistic from Livneh and Antonak 
(1990). d Normative data from Schönberger et al. (2014). 
 
If RC was established, the data was assessed for CSC. CSC was first 
introduced by Jacobson, Follette and Revenstorf (1984) and was defined as change 
that moves an individual from the clinical to non-clinical range on a given measure. 
Jacobson and Traux (1991) offered three ways of establishing CSC: A) the individual 
must move more than two standard deviations (SD) from the mean of the clinical 
group; B) they must move to within two SD of the non-clinical population mean; and 
C) the individual’s post-treatment scores must be closer to the mean of the non-clinical 
than the clinical population (i.e., scores cross the ‘cut-off point’, midway between the 
clinical and non-clinical population means). However, depending on the 
circumstances of the data, others have argued that using one SD (Sheldrick et al., 
2001) or 0.5 SD (Norman, Sloan & Wyrwich, 2003) for criterion A and B can be more 
appropriate.  
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 Criterion C (viewed as the least arbitrary) was used to analyse HADS-D data 
due to an overlap between clinical and non-clinical populations (Jacobson & Traux, 
1991). This meant that for CSC to be met, participants post-intervention scores were 
required to be closer to the non-clinical mean than the clinical mean (see Table 7). As 
both the QOLIBRI and RIDI are brain injury and disability specific measures 
without a non-clinical normative sample, criterion A was chosen; however, when a 
SD of two was used, this exceeded the upper limit of both measures. Therefore, a SD 
of one was used to maintain a meaningful criterion. To meet CSC, participants post-
intervention scores were therefore required to move more than one SD from the 
mean of the clinical group (see Table 7). 
Results 
Results will be presented by outlining: (1) participant information; (2) process 
measure findings from the Values Bullseye; (3) SCED data; (4) standardised measures 
completed at T1, T2, T3 and T4; (5) findings related to future thinking, and (6) 
findings related to acceptability. 
Participant Information 
Table 8 reports sociodemographic information for each client. Four 
individuals took part in the study (Pt1, Pt2, Pt3, Pt4 determined in chronological order 
of participation) with an average age of 51.75 years (SD=5.5). Three participants were 
White British, speaking English as their native language, and one participant was 
Polish, speaking English as their second language. Pt1 and Pt4 acquired their injuries 
within six months of starting the study. Pt2 and Pt3 acquired their injuries 
approximately five and nine years beforehand. Prior to acquiring their injuries, three 
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participants were in paid employment (Pt1, Pt2, Pt4). At the time of their research 
involvement, all participants used a wheelchair, required support with activities of 
daily living (e.g., washing and dressing), and were undergoing differing levels of 
neurorehabilitation. All participants were receiving pharmacological treatment, with 
two individuals taking psychotropic medication for low mood and reduced 
engagement (Pt2, Pt4: Sertraline). Pt2 received therapy alongside the values-
intervention. This focused on managing COVID-19 anxiety and overlapped with the 
final session of the values intervention. Pt1 and Pt3 contracted COVID-19 during 
their participation. Throughout the study there were strict restrictions in place due to 
COVID-19. At times, this meant that participants could not leave their ward or bays. 
Additionally, hospital and home visits were not possible throughout; thus, participants 
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right midbrain & 
small left parietal 
haemorrhage) 
Dysphasia. Impaired 
attention and memory 




Previously lived in 
house share 
In daily contact 





The Values Bullseye was used to examine hypothesis one (i.e., that the 
intervention would increase valued behaviour). This recorded how closely aligned to 
their values each participant believed themselves to be living in the early stages of 
therapy (session 1 or 2), midway through therapy, post-therapy and at follow-up. As 
hypothesised, self-reported values-based behaviours increased for all participants over 
the course of therapy (Table 9). 
Table 9 
Findings from the Values Bullseye 
Pt Value Early-therapy Mid-therapy Post-therapy Follow-up 
1 Love 
Fun 
3.5             
1.75  
1.5                
1.75 
0.5           
0.5 
0         
0.5 
2 Connection    
Love & sexuality 
2.5    
4 
1.5               
3.5 
1                 
3.5             
1              
3.5 
3 The environment 2.5 1.75 1.5 1.5 
4 Courage 3.5 - 2.5 - 
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Note. 0-4 scale where 0 indicates living completely in line with the value. Pt4 
completed the Values Bullseye on two occasions due to shortened therapy 
involvement and being discharged prior to follow-up. 
 
Analysis of SCED data 
Each participant’s self-reported mood and meaningful behaviour was 
measured using VAS throughout the three study phases. It was hypothesised that as 
the intervention progressed, participants would report increased meaningful 
behaviour and a reduction in low mood when compared to baseline. Below, each 
participants VAS data is discussed in turn by firstly outlining their therapeutic 
engagement and extraneous factors that were relevant during the different treatment 
stages; and secondly, by reporting visual and Tau-U statistical analysis. VAS data is 
presented visually using line graphs (Figures 4-11), on which raw data is depicted in 
blue. Lines denoting the central tendency and overlap of data are included (see Figure 
3), and a series of black dots mark trendlines. Black vertical lines indicate the change 







Key for Central Tendency and Overlap Ranges Indicators used for Participants VAS graphs 
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Participant 1 (Pt1) 
 Therapeutic Engagement. Pt1’s involvement began three weeks into his 
admission. He was randomised to a four-week baseline before attending five sessions 
across three weeks. He attended all planned sessions. During this time, he was 
undergoing intensive rehabilitation including daily physiotherapy, occupational 
therapy, and speech and language therapy sessions. In the first stage of the 
intervention (i.e., values clarification and reflection), he was able to quickly grasp the 
idea of values, identifying two values of most importance to him, which he hoped to 
move closer towards during his admission (love and fun). In stage two of the 
intervention (i.e., goal setting), he was able to generate many values-based goals to 
work towards. For example, he wanted to make his children a Christmas present and 
to host a Christmas party for the ward. As therapy progressed, he also began to 
engage in self-directed values-based behaviours; for instance, he decided to write a 
love letter to his wife and began to have conversations with other patients about their 
shared values. In stage three of the intervention (i.e., addressing obstacles), he required 
increased support due to his cognitive difficulties (e.g., reduced problem solving). 
Barriers that could obstruct him from living by his values once discharged were 
considered and he decided to share his values with his partner who could support him 
at home. His VAS data are depicted in Figure’s 4-5.  
Notable Extraneous Factors. During his baseline, Pt1 experienced 
frequent periods of low mood, which he attributed to being away from his family. 
This was exacerbated by his cognitive difficulties. For example, his concrete state 
thinking and inability to think flexibly meant that he could become stuck in negative 
automatic thoughts (e.g., thoughts that his wife might leave him due to his stroke) and 
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was very focused on being ‘home for Christmas’. Towards the end of his baseline, he 
received upsetting news from his family, which made him feel ‘very worried and 
weepy’. At this time, he also experienced fleeting suicidal thoughts (without intent). At 
the end of the intervention (point B11, Figures 4-5) he contracted COVID-19, 
delaying his discharge by two weeks, and meaning he could not go home for 
Christmas. Due to COVID-19 restrictions, it was not possible to attain VAS measures 
whilst he was infected (weeks seven to nine of his participation). In week nine, Pt1 was 
discharged. His follow-up therefore took place at home two weeks post-discharge (one 
month after his final research therapy session). Being at home helped him to feel more 
connected to his family but also triggered worry and low mood due to the challenges 
of living more independently and having to rely more on others.  
W5 W1 W2 W4 W3 W6 W7 W11 
Figure 4 
Pt1: Raw VAS Data for Low Mood 
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Note. W=Week. Each data point represents his self-rating from 0-10 over 24-hours. 
Note. W=Week. Each data point represents his self-rating from 0-10 over 24-hours. 
Visual and Tau-U Analysis. Tau-U confirmed a significant upward trend 
in Pt1’s baseline for low mood (Tau-U=.50, p<.01). This was corrected for in 
comparison analyses. His mood deteriorated towards the second half of baseline 
(coinciding with difficult news from his family), but this trend reversed during the 
intervention phase, demonstrating a slight reduction in depression on starting therapy. 
However, there is little overall change in the means between phases. Tau-analysis 
indicated no significant differences in low mood between baseline and intervention 
with a large degree of overlap (Tau-U=-.22, p=.32), suggesting that the interventions 
influence on this variable was small. 
W5 W1 W2 W4 W3 W6 W7 W11 
Figure 5 
Pt1: Raw VAS Data for Meaningful Behaviour 
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Pt1’s baseline for meaningful behaviour fluctuated markedly, with no clear 
trend. Whilst the deterioration seen in the first week of his intervention may relate to 
the start of treatment, such fluctuations were also present during his baseline phase, 
making it less likely that the intervention influenced this reduction. In weeks five and 
six of his participation, two upwards trends are noted in meaningful behaviour, 
coinciding with the values-based goal setting phase of the intervention. As depicted in 
Figure 5, the means across phases show an increase in meaningful behaviour during 
the intervention, which approached significance (Tau-U=.42, p=.06). During his 
follow-up, Pt1 scored at ceiling for meaningful behaviour. This coincided with him 
returning home, which increased opportunities to connect with his values. TAU-U 
analysis outlines a significant difference in meaningful living when baseline is 
compared to intervention and follow-up combined (Tau-U=.53, p=.03). 
Participant 2 (Pt2) 
 Therapeutic Engagement. Pt2 was an inpatient in long-term care. His 
participation in the study began two years into his admission when he was randomised 
to a three-week baseline. He attended seven sessions over seven weeks with no sessions 
declined. During this time, he was receiving less intensive rehabilitation (i.e., less 
physiotherapy and speech and language therapy) than usual, due to COVID-19 
restrictions. Also due to COVID-19, the values intervention took place over videocall. 
He engaged well with the intervention, quickly identifying ‘connection’, ‘love’ and 
‘sexuality’ as important values to him. He identified many ways in which he already 
connected to others, despite the barriers associated with being in hospital, and was 
able to generate future goals that aligned to this value (e.g., to join an online brain 
injury forum). As with other participants, he also began to engage in self-directed 
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behaviours in addition to those discussed in sessions (e.g., he initiated a telephone call 
with a different friend every week). VAS graphs outlining his research involvement are 
presented in Figure’s 6-7. 
Extraneous Factors. Week six of his involvement (third intervention week) 
fell between Christmas and New Year’s Eve. This meant that there was a week break 
between sessions and less opportunities to engage in activities on the ward (see Figure 
7 for a reduction in meaningful behaviours), mostly due to COVID-19 restrictions. In 
weeks seven to nine, he began to experience severe spasms, leaving him bed bound. 
This created challenges for engaging with meaningful behaviours. In week eight, Pt2 
expected his second COVID-19 vaccine, which he was anxious to receive. However, 
this was delayed, and he experienced intense worry, anger, and frustration due to his 
physical vulnerability and necessary dependence on others (see Figure 6). His 
caregivers and friends described him engaging in frequent rumination about 
contracting the virus, which began to impact on his ability to concentrate and to 
engage with the sessions. For this reason, in the penultimate week of his intervention 
phase (week nine of his research involvement), he began sessions with a member of the 
hospital psychology team focusing solely on anxiety management. The timings of his 
antidepressant medication (Sertraline, 125mg) were also amended at this time, though 
the dose remained consistent. In week 12, the second week of his follow-up, his 
anxiety management sessions came to an end. 
Figure 6 
Pt2: Raw VAS Data for Low Mood 
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Note. W=Week. Each data point represents his self-rating from 0-10 over 24-hours. 
W5 W6 W1 W2 W3 
 
W7 W9 W8 W10 W11 W12 W4 
= 
Figure 7 
Pt2: Raw VAS Data for Meaningful Behaviour 
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Note. W=Week. Each data point represents his self-rating from 0-10 over 24-hours. 
Visual and Tau-U Analysis. Pt2’s baseline for low mood was variable, with 
an upward yet non-significant trend evident (Tau-U=.27, p=.22). This trend reversed 
on commencement of the intervention, and a reduction in low mood was noted 
between weeks four to seven, corresponding with the values clarification and goal-
setting phases of the intervention. However, the trend reversed again in week eight 
(i.e., week five of therapy) when an increase in depression was consistent with the 
increase in his spasms and the cancellation of his second vaccine. Overall, there was 
little change in the mean for low mood between baseline and intervention phases 
(Tau-U=.07, p=.73). During the first week of his follow-up, his mood appeared to 
improve and stablise; however, by the second week an upward trend in low mood was 
W4 W5 W6 W1 W2 W3 
 
W7 W9 W8 W10 W11 W12 
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evident once more. It is unclear whether this related to the withdrawal of the research 
therapy and/or another extraneous variable (e.g., his anxiety management sessions 
ending). No significant differences were found when baseline was compared to 
intervention and follow-up phases combined (Tau-U=-.02, p=.91) 
For meaningful behaviour, a slight downward trend was observed during 
baseline, though this did not reach significance (Tau-U=-.32, p=.15). Between weeks 
six to eight, corresponding with sessions focussing on values-based goal setting, an 
upward trend and stablisation of meaningful behaviour is evident. However, as with 
depression, this trend reverses in week nine. Overall, there is little change in the mean 
for meaningful behaviour between baseline and intervention (Tau-U=-.07, p=.73). 
During his follow-up period, there is a clear downward trend in meaningful 
behaviour; however, TAU-U analysis again outlines no significant differences and a 
large overlap between baseline, and intervention and follow-up phases combined 
(Tau-U=.09, p=.67).  
Participant 3 (Pt3) 
 Therapeutic Engagement. Pt3’s participation began approximately 18 
months after her admission. She was randomised to a three-week baseline before 
attending seven sessions over seven weeks. No sessions were declined but due to 
COVID-19 restrictions, sessions were occasionally rescheduled. During this time, she 
was also receiving less intensive rehabilitation than other participants. In early 
discussions, she reflected that becoming unwell had encouraged her to think about 
what really mattered to her. She outlined several ways in which she was living more 
closely to her values compared to pre-injury (e.g., by staying connected to her children 
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despite being unable to see them in person). Initially, she found it difficult to identify 
values that (1) were important to her and (2) she thought there was scope to live more 
closely to whilst in hospital. However, with support, she identified protecting the 
environment as being deeply meaningful to her and identified new values-based goals 
(e.g., to learn more about the environment and to discuss ways of looking after the 
environment with others). VAS graphs outlining her research involvement are 
presented in Figure’s 8-9. 
Extraneous Factors. Approximately one month before her baseline began, 
Pt3 was diagnosed with basal cell carcinoma. The tumour was operated on and 
removed prior to her research involvement. Throughout her baseline and intervention 
phases, she attended several medical appointments to review her progress. As with 
other participants, COVID-19 restrictions meant she had been unable to see her 
children for six months prior to her baseline and throughout the study. In the final 
week of the intervention phase, she contracted COVID-19 and was extremely unwell, 
meaning that there was a significant gap (12 weeks) between her final two sessions. In 
her final session, she reported that she was slowly recovering though had not yet 
returned to her baseline functioning. 
Figure 8 
Pt3: Raw VAS Data for Low Mood 
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Note. W=Week. Each data point represents his self-rating from 0-10 over 24-hours. 
W10 W9 W8 W1 W2 W19 W3 W20 W5 W6 W7 W4 
Figure 9 
Pt3: Raw VAS Data for Meaningful Behaviour 
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Note. W=Week. Each data point represents his self-rating from 0-10 over 24-hours. 
Visual and Tau-U Analysis. Pt3 scored at floor for low mood throughout 
her baseline. This continued without fluctuation through intervention and follow-up 
phases, suggesting that the intervention had no impact on this variable. This is 
contradictory to symptoms reported on standardised measures (see HADS-D results 
below), and may relate to several factors including issues with measurement, 
particularly within the ABI population (see Discussion). 
In terms of meaningful behaviour, an upward trend is evident during the first 
two weeks of the intervention (weeks four to five of her participation), corresponding 
to the identification of her values and initial discussions about value-consistent 
behaviours. A slight downward trend was observed across the remainder of the 
intervention. However, the mean across phases indicates an overall increase in 
W10 W9 W8 W1 W2 W19 W3 W20 W5 W6 W7 W4 
 118 
meaningful behaviour in the intervention phase compared to baseline, which was 
confirmed by TAU-U analysis (Tau-U=.57, p<.01). The fact that this was not 
maintained at follow-up may relate to the withdrawal of the intervention. However, 
her follow-up took place three months after her research involvement when she was 
recovering from COVID-19, which significantly impacted her day-to-day functioning. 
Participant 4 (Pt4) 
 Therapeutic Engagement. Pt4’s research involvement began five weeks 
into her admission when she was randomised to a two-week baseline. She attended 
five sessions across five weeks, with sessions coming to an end the week of her 
discharge. No sessions were declined. In the early stages of the intervention, she 
identified ‘courage’ as a value that she hoped to work towards, stating “you have to 
live with your fears” and “find the courage to smile again”. In the goal-setting stage of 
therapy, she was supported to develop specific goals that aligned to her value of 
courage (e.g., to show her face on videocall to her partner, and to tell her family how 
she felt). Although the idea of carrying out these goals caused her to feel anxious, she 
was encouraged to approach things that were meaningful to her, considering how she 
might prevent the anxiety from ‘squashing’ her courage. In later sessions, she began to 
think about how she could continue to live by her values in the future. She started to 
engage in self-directed values-based behaviours; for instance, she decided to move 
back to Poland on discharge, reporting that this was a huge act of courage. VAS 
graphs outlining her research involvement are presented in Figure’s 10-11. 
Extraneous Factors. In the first week of Pt4’s baseline, her tracheostomy 
was removed. She was worried that this may be reinserted and reported feeling 
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increasingly low in mood. She began to take antidepressant medication (Sertraline, 
50mg) in week three of her participation (first intervention week); however, she 
continued to experience low mood throughout the intervention and reported that the 
medication had not helped. In week five of her participation (third intervention week), 
she explained that due to a language barrier, she was struggling to understand what 
had caused her stroke and was frequently worrying about why her tracheostomy 
stoma had not healed. Additionally, she reported feeling low and as though she was 
no longer the person she once was. Such worries frequently prevented her from 
sleeping and she began to disengage from all rehabilitation sessions except for the 
research intervention. 
Figure 10 
Pt4: Raw VAS Data for Low Mood 
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Note. W=Week. Each data point represents his self-rating from 0-10 over 24-hours. 
Note. W=Week. Each data point represents his self-rating from 0-10 over a 24-hours. 
Visual and Tau-U Analysis. As outlined in Figure 10, a downward trend 
in low mood is evident during the first week of Pt4’s baseline. However, this trend 
reverses in week two of her baseline, outlining increased low mood that corresponded 
to her tracheostomy concerns. Throughout the intervention phase, there is no clear 
trend in low mood. Whilst means outline an increase in low mood during the 
intervention phase when compared to baseline, TAU-U analysis found no significant 
differences and a large overlap between phases (Tau-U=.24, p=.34). 
Similarly, Figure 11 outlines an upward trend in meaningful behaviour during 
the first week of her baseline, which reversed during the second week. On the 
Figure 11 
Pt4: Raw VAS Data for Meaningful Behaviour 
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commencement of therapy, scores for meaningful behaviour appeared to increase and 
stablise, with small fluctuations evident across the intervention phase. Overall, phase 
means demonstrate increased meaningful behaviour during the intervention when 
compared to baseline. This is supported by TAU-U analysis, which confirms a 
significant increase in meaningful behaviour during the intervention (Tau-U=.53, 
p=.03). 
Summary of SCED Data 
For the low mood VAS, none of the participants demonstrated significant 
change from baseline through to intervention or follow-up. Both Pt1 and Pt2 showed 
an initial downward trend in low mood between sessions one to four of the 
intervention (Pt1: weeks 5-6; Pt2: weeks 4-8); however, for both participants this trend 
reversed briefly, corresponding to changes in personal circumstances. Low mood VAS 
remained stable for both Pt3 and Pt4 during their participation, with Pt3 scoring at 
floor and Pt4 close to ceiling throughout.  
Contrary to findings from the Values Bullseye, which tracked specific values 
identified in therapy (and showed steady improvements for all participants), Pt3 and 
Pt4 were the only participants to show significant increases in meaningful behaviour 
during the intervention phase when compared to baseline. This was not maintained at 
follow-up for Pt3, however. Although Pt1 demonstrated an increase in meaningful 
behaviour during intervention, this fell short of significance when compared to 
baseline (p=.06), reaching significance when baseline was compared to intervention 
and follow-up combined (Tau-U=.53, p=.03). No significant differences in meaningful 
behaviour were observed for Pt2 across phases. As replication of effect was not shown 
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for either variable across timepoints and participants, effect size was not calculated 
(Kratchowill et al., 2010).  
Analysis of Standardised Data 
Standardised measures assessed each participants symptoms of depression 
(using HADS-D), quality of life (using QOLIBRI Self and Emotions) and adjustment 
(using RIDI – Adjustment) pre-baseline (T1), pre-intervention (T2), post-intervention 
(T3) and follow-up (T4). It was hypothesised that following the intervention, 
participants would report lower levels of depression, improved quality of life and 
increased adjustment to their injury. The Leeds Reliable Change Indicator was used to 
graph data and to determine whether participant’s achieved reliable change (RC) and 
clinically significant change (CSC) (Morley & Dowzer, 2014). The scatter plots below 
display each participants’ pre to post-intervention scores. For pre-intervention scores, 
an average was calculated between participant responses at T1 and T2. T4 scores are 
used as post-intervention scores for all participants except for Pt4 who was discharged 








Note. Criterion C used for CSC. 
Three participants (Pt1, Pt2, Pt3) reliably improved and met CSC for 
depression at T3. Pt4 showed a reduction in depression, however, this did not meet 
threshold for being ‘reliable’. At T4, two participants (Pt2, Pt3) continued to meet 
criteria for reliable and clinically significant improvement, whereas Pt1 did not 
reliably change when compared to pre-intervention. 
Quality of Life (QOLIBRI Self and Emotions subscales) 
Figure 13 
Comparison between Pre-intervention and Follow-up QOLIBRI-Self Scores (n=4) 
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Note. Criterion A used for CSC.  
None of the participants reliably changed on quality of life scores measuring 
self-perception at T3 compared to pre-intervention. Similarly, at T4, Pt1 and Pt3 did 
not significantly change when compared pre-intervention; however, Pt2 deterioriated, 
meeting clinical significance.  
Figure 14 
Comparison between Pre-intervention and Follow-up QOLIBRI-Emotions Scores (n=4) 
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Note. Criterion A used for CSC.  
For the Emotions subscale of the QOLIBRI, Pt1 reliably improved at T3 and 
T4 compared to pre-intervention, meeting clinical significance at both time points. No 
reliable change occurred for Pt2, Pt3 or Pt4 at T3, nor for Pt2 and Pt3 at T4. 
Adjustment (RIDI)  
Figure 15 
Comparison between Pre-intervention and Follow-up RIDI-Adjustment Scores (n=4) 
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Note. Criterion A used for CSC.  
At T3,  Pt1 and Pt3 reliably improved for adjustment, with Pt1 meeting CSC. 
Adjustment did not reliably change for Pt2 or Pt4 at this time. At T4, Pt3’s scores 
remained stable, reliably improving but not reaching clinical significance, whilst 
adjustment did not reliably change for either Pt1 or Pt2. 
Summary of Standardised Results 
Three out of four participants experienced reliable and clinically significant 
reductions in depression at T3, which were maintained at T4 for two participants. 
The QOLIBRI-Self subscale showed the least change, with no participants showing 
reliable change at T3 and one participant demonstrating a deterioration at T4.  
 Pt1 responded to treatment best, reliably and clinically improving on three out 
of four measures at T3 (HADS-D; RIDI; QOLIBRI-Emotions) and maintaining 
improvement on the QOLIBRI-Emotions at T4. Pt4 showed the least improvement 
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post-intervention, with no meaningful change detected. Pt2 was the only participant 
to reliably deteriorate on any measure (T4: QOLIBRI-Self). When considering 
standardised data alongside the VAS findings, inconsistencies are evident. That is, 
despite standardised measures showing clinically improved mood for three 
participants immediately post-intervention, no participant demonstrated significant 
changes in depression on VAS measures between baseline and intervention phases.  
Future Thinking  
It was hypothesised that, due to heightened depression scores, participants 
would demonstrate a negative bias in prospective cognition pre-treatment, which 
would reduce throughout the intervention. The FFT measured biases in prospective 
cognition at T1, T2, T3 and T4, with pre-intervention scores calculated by taking an 
average of T1 and T2 responses. Participants were given one minute to generate as 
many likely or plausible self‐future experiences as possible for three time periods (next 
week, next year, and the next five to ten years). The total positive versus negative 
items were computed for each participant by summing across time periods. Positive 
bias was then calculated as the proportion of positive items out of all items generated 




Findings from the Future Thinking Task Converted to Positive Bias Scores of 0-1 
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Pt Condition T1/T2 T3 T4 
1 Positive 
Negative 

















10     




3 Positive  
Negative    










4 Positive  
Negative    










Note. Scores >.5 = positive bias, scores <.5 indicate negative bias. Pt4 lost to follow up. 
Pre-intervention, none of the participants demonstrated a negative bias in 
future thinking. Over the course of therapy, Pt1 and Pt2 demonstrated an increased 
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positive bias, with Pt1 exhibiting the largest change. Scores for Pt3 and Pt4 remained 
relatively stable, suggesting that the intervention did not impact their future thinking. 
No participant deteriorated across the course of therapy. 
Acceptability of the Intervention  
Client feedback, adherence to the protocol and recruitment and retention were 
considered when evaluating the acceptability of the intervention. To assess therapist 
competence, approximately 20% of therapy sessions were listened to by the therapist’s 
Academic Supervisor, all of which were found to adhere to the protocol. Prior to 
publication, the therapist’s Academic Supervisor will formally rate protocol adherence 
using the values-based parts of an ACT-specific adherence manual previously used in 
an ACT trial for OCD (Twohig et al., 2010). Figure 2 (see Methods) outlines full 
information relating to recruitment and retention. For several reasons, the 
recruitment target of six participants was not achieved within the proposed timeframe. 
Firstly, due to COVID-19, one of the two proposed research sites had stopped all 
non-covid related research; thus, it was not possible to recruit from this site. Secondly, 
the remaining recruitment site went into lockdown, dividing the hospital into ‘zones’ 
that could not be crossed, severely limiting the participant pool. Finally, two 
participants were withdrawn from the study. One participant withdrew during their 
baseline phase, due to an early discharge after contracting COVID-19. The second 
participant was withdrawn during their intervention phase, due to a significant rise in 
their risk following a separation from their partner. The research therapy was not 
reported to have contributed to this increase in risk. The CSQ was used to attain 
quantitative feedback from all clients that completed the intervention, as outlined in 
Table 11.  
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Table 11 
CSQ Total Scores Converted to Acceptability Ratings of 0-100 
 
Pt Therapist CSQ raw score /32 Acceptability /100 
1 1 29 90.6 
2 1 32 100 
3 1 32 100 
4 2 22 69 
Note. Therapist 1 (RA)=final year clinical psychology trainee. Therapist 2 
(SS)=Qualified Clinical Psychologist.  
 
The acceptability of the values-based therapy was rated between 69 and 100% 
across the two therapists. All participants stated that the intervention was helpful and 
supportive and that they would complete a similar therapy if needed. Whilst other 
participants appeared to benefit from the present focus and short-term nature of the 
therapy, Pt2 reported that he would have appreciated further exploration of his past 
experiences (particularly relating to his relationships) and a longer-term therapeutic 
approach. Some participants commented that it felt novel to think about their values 
and that such conversations were often avoided by others in their life, whereas others 
reported that they had thought a lot about their values since their brain injury. Some 
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participants therefore benefited from the therapy reinforcing their existing values-
based behaviour, whereas others benefited from the introduction of new behaviours. 
Overall, the intervention was found to be useful and was reported to have encouraged 
ongoing values-based thinking and behaviour. 
Discussion 
This study examined the use of a values-based intervention for 
neurorehabilitation inpatients with an ABI and symptoms of depression. The effect of 
the intervention was assessed using outcomes of valued behaviour, mood, quality of 
life, adjustment to brain injury and future thinking. The novel intervention was the 
first to draw upon the behavioural components of ACT (i.e., values and committed 
action) within this population. Mental imagery was an optional component of the 
intervention aimed at increasing motivation towards values-based goals; however, due 
to participants exhibiting high levels of motivation and positive biases in future 
thinking at baseline (evidenced by scores on the Future Thinking Task), imagery use was 
not indicated. Therefore, no imagery was delivered in the study. 
Main Findings 
Four participants attended an average of six one-to-one intervention sessions 
and one participant was lost to follow-up (moved countries). For all but one 
participant, standardised data outlined reliable and clinically significant change on at 
least one variable. Depression was the most improved variable, with three out of the 
four participants demonstrating reliable and clinically significant reductions on the 
HADS-D at T3. Two individuals maintained these reductions at T4. Adjustment was 
second to depression, with two participants reliably improving at T3, one of whom 
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met clinical significance; however, this was maintained for only one participant at T4. 
The Quality of Life ‘Self’ subscale, which assessed participants self-perception, 
outlined the least positive change. None of the participants reliably improved at either 
T3 or T4, with one participant reliably deteriorating at T4 and meeting clinical 
significance. 
In terms of SCED data, low mood VAS did not significantly differ between 
study phases (i.e., baseline, intervention, follow-up) for any participant, suggesting that 
the intervention had little effect on daily reporting of mood. For three of the four 
participants, inconsistencies between the low mood VAS and standardised HADS-D 
data were therefore evident (i.e., participants demonstrated reductions in depression 
on the HADS-D with no significant changes in VAS for low mood). This may relate 
to a number of factors. Firstly, VAS were administered as close to daily as possible 
whereas the HADS-D was only administered at four timepoints throughout the study. 
Hence, VAS were more likely to be influenced by extraneous variables (e.g., 
interactions with family or staff members and the changing COVID-19 restrictions 
within the hospital). Secondly, specific instructions and pre-defined categories, which 
are provided on the HADS-D, are not provided for VAS measures, arguably allowing 
for more subjectivity in their completion (Klimek et al., 2017); hence, participants 
may not have considered the symptoms of depression assessed on the HADS-D in 
their daily mood ratings. Thirdly, common cognitive deficits (e.g., in memory and 
executive functioning) likely affected participants self-report of earlier experiences and 
emotions; thus, they may have answered based on how they felt in-the-moment as 
opposed to accurately reflecting on the specified time-period. This is most likely to 
have impacted on the HADS-D, which covered a two-week period, rather than the 
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VAS which covered a 24-hour period. Finally, the HADS-D was administered by the 
researcher, which may have introduced bias through demand characteristics. On 
some occasions, the researcher was present for VAS data collection, but on most this 
was not the case. 
In terms of the meaningful living VAS, two of the four participants 
demonstrated significantly increased meaningful behaviour during the intervention 
phase when compared to baseline. For one participant, this was not maintained 
during the follow-up phase, with the second participant lost to follow-up. A third 
participant also demonstrated increased meaningful behaviour during the intervention 
and follow-up phases, though, this fell short of significance when compared to 
baseline. Despite VAS outlining some improvements in meaningful living, a clear 
effect of intervention was therefore not detected; that is, reliable improvements from 
week two of the intervention were not demonstrated for at least three participants 
across different baselines (as required when establishing causality in a MBD; Horner 
et al., 2005). 
In contrast, the Values Bullseye outlined an increase in value-consistent 
behaviour during the intervention for all four participants. Such increases were 
maintained for the three participants who completed follow-up. What’s more, 
throughout the intervention, most participants began to engage in self-directed values-
based behaviours in addition to goals forumulated in sessions; thus, highlighting that 
participants were able to take some ownership of valued living and focus on the values 
themselves rather than the pursuit of specific goals. Discrepencies between the 
Bullseye and VAS measures are similar to those reported by Sharma (in prep) and 
may relate to the fact that the Bullseye tracked specific values that were identified 
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early in therapy, whilst the VAS measured meaningful living more broadly. Arguably, 
the VAS scale therefore allowed for increased subjectivity when interpreting what was 
‘meaningful’, and participants may not have considered values in their responses. For 
example, on several occassions, participants reported basing their VAS scores on their 
experience of their rehabilitation that day; that is, how meaningful they had percieved 
other sessions (e.g., physiotherapy) to be. Consequently, the two scales likely captured 
different concepts. Despite inconsistencies, there is some evidence from this study that 
the intervention did increase values-based behaviour in this ABI group. As outlined 
below, this is in line with previous findings in both non-ABI (Villatte et al., 2016) and 
ABI (Sharma, in prep) populations. 
Finally, in terms of future thinking none of the participants demonstrated a 
negative bias in future thinking pre-intervention (i.e., all participants reported more 
positive than negative plausible future events). This is opposing to previous research, 
which found a negative bias in future thinking in both ABI (Murphy et al., 2019) and 
non-ABI (Matthews & MacLeod, 2005) groups with depression. Across the course of 
therapy, two of the four participants exhibited an increased positive bias at T3 and 
T4, showing both an increase in positive future thoughts and a decrease in negative 
future thoughts. In relation to standardised and VAS data, both participants 
demonstrated significant reductions on the HADS-D at T3, one of which was 
maintained at T4; however, neither of the participants outlined significant changes on 
the low mood or meaningful living VAS (though, one participant approached 
significance for meaningful living). For the two participants that demonstrated stable 
future thinking scores, only one participant demonstrated reductions in depression on 
the HADS-D at either T3 or T4, neither outlined reliable reductions on their daily 
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mood reporting, and both outlined significant increases in meaningful living on the 
VAS, though this was not maintained into follow-up. Thus, in line with previous 
research (Murphy et al., 2019), this study showed some evidence of improved future 
thinking that corresponded to reductions in standardised depression scores. However, 
increased meaningful living on the VAS did not consistently correspond to 
improvements in mood and future thinking. Such findings may be explained by the 
ACT literature, which highlights ACT as aiming to increase functioning in the face of 
distress (Hayes et al., 2006) and proposes that acting in line with values is not 
necessarily enjoyable or mood enhancing (Harris, 2008). 
According to standardised feedback, all participants found the intervention to 
be acceptable. All were able to identify their values, establish value-consistent goals 
and work towards these over the course of the intervention. Although two participants 
were withdrawn from the study, this was due to factors unrelated to the research 
intervention (an early discharge and a change in personal circumstances). This is 
particularly promising as previous SCEDS have outlined dropout rates of 20% or 
more (e.g., Jamieson et al., 2019), with high attrition rates also reported for other 
psychological therapies within ABI groups (Gertler et al., 2015). 
Findings in Relation to Previous ACT Research 
The standardised and VAS data outlined above are supported, in part, by 
previous research. For instance, researchers have demonstrated reductions in 
depression following individual (Whiting et al., 2017) and group-based (Whiting et al., 
2019) ACT treatments in neurorehabilitation, as well as in ABI-groups more widely 
(e.g., Majumdar & Morris, 2019). Similarly, improvements in psychological distress 
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and adjustment are reported in studies using only the values and committed action 
components of ACT in non-ABI groups (Villatte et al., 2016); however, this 
corresponds only to the standardised, not VAS, findings in the present study. 
Moreover, Villatte et al. also reported quality-of-life improvements, which were not 
replicated in the current study; in fact, the self-perception subscale of the quality-of-
life measure was the only measure on which any participant reliably deteriorated post-
intervention. In ABI groups without depression, the valued and committed action 
components of ACT have also led to improvements in mood and adjustment on 
standardised measures (Sharma, in prep), again supporting the present findings. 
However, unlike the present study, Sharma found that VAS for low mood was also 
improved for most participants post-intervention. This may relate to the fact that, in 
contrast to participants in the present study, four of the six participants did not meet 
the threshold for depression at baseline in addition to issues with measurement as 
outlined above. In terms of meaningful living, Sharma found that all participants 
reported increased values-consistent behaviour on the Values Bullseye; though, 
similarly to the present study, this did not always translate onto the meaningful living 
VAS, which improved for just two of the six participants.  
Methodological Issues  
Various methodological issues arose during the study. For instance, given that 
all participants were neurorehabilitation inpatients, extraneous factors relating to their 
rehabilitation (e.g., the stage and progress of their rehabilitation and their access to 
social support) may have influenced the evaluation of the intervention (Sohlberg & 
Mateer, 2001). The main challenges of conducting research within this environment 
are discussed below.  
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 The four participants were at vastly different stages of their rehabilitation, and 
thus exhibited differing levels of progress and adjustment. Two participants were 
inpatients in long-term care, with predicted discharge dates at least two months after 
their study involvement ended (Pt2, Pt3), whereas two participants were seen up until 
their discharge from rehabilitation (Pt1, Pt4). Interestingly, considering both VAS and 
standardised data, Pt1 demonstrated the greatest overall improvement, suggesting that 
being closer to discharge positively impacted treatment response. In contrast, Pt4 
displayed the least improvement across measures, indicative of the opposite. This may 
be explained by the complex and idiosyncratic response experienced by individuals 
around discharge. For instance, Pt1 reported feeling excited by going home and 
demonstrated an increase in valued behaviour once back with his family. However, he 
also demonstrated a slight increase in low mood that corresponded to having to adapt 
to the home environment and his increased reliance on family members. Pt4, on the 
other hand, reported feeling extremely anxious about being discharged and struggled 
to make important decisions about discharge location (i.e., whether she would return 
to Poland). Although, such factors may have been controlled by recruiting participants 
that followed the same rehabilitation trajectory (i.e., starting and finishing at the same 
time), this would be difficult to control due to the frequent changing of discharge dates 
within this setting. Additionally, individual circumstances, thoughts and feelings 
towards discharge would likely continue to impact on findings. 
 Understandably, findings were impacted further by participants’ experience of 
their rehabilitation and being in a hospital environment during the COVID-19 
pandemic. For instance, both Pt1 and Pt3 contracted COVID-19 during their 
research involvement (in both cases, towards the end of the intervention and 
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overlapping with the follow-up stage of the study). Both participants reported that this 
impacted on their responses to study measures due to on-going feelings of fatigue and 
an inability to engage in enjoyed activities whilst unwell. Additionally, for all 
participants, COVID-19 restrictions meant that they were unable to have visitors 
throughout their admission, often had reduced therapy input, as well as being unable 
to leave their wards and, at times, their bays for prolonged periods of time. 
Participants reported feeling low in response to these restrictions, missing their 
families, and feeling increasingly bored. What’s more, restrictions impacted heavily on 
the values-based goals set during therapy (e.g., activities had to be feasible on the ward 
or virtually). 
 Finally, factors such as participants’ cognitive ability and level of insight may 
have also influenced outcomes. For instance, executive functioning (e.g., inflexibility, 
poor attention, and impaired reasoning and judgement) and memory difficulties were 
experienced by all four participants and may have affected their self-ratings. 
Difficulties remembering recent information and switching attention were particularly 
apparent for Pt1 and Pt2 who often based their overall daily or fortnightly ratings on 
their in-the-moment experience rather than reflecting on specified time-periods. 
Furthermore, all participants demonstrated concrete thinking styles, which may have 
contributed to more extreme ratings (e.g., Pt3 scoring at floor for the low mood VAS 
throughout her study involvement). Other explanations for floor ratings include 
reduced insight, which commonly results from organic impairment or psychological 
denial after ABI (Langer & Padrone, 1992). Improved insight can be achieved 
through neurorehabilitation sessions, emotional support, and/or cognitive recovery, 
and often correlates to reduced mood in ABI groups (Sohlberg & Mateer, 2001). 
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Thus, this may have also contributed to the lack of improvement seen in low mood 
across participants on daily VAS measures.  
Strengths and Limitations 
A particular strength of the study was the use of a SCED with baseline 
randomisation, which overcame some limitations of the existing research in this area 
and allowed for robust control of threats to internal validity. For example, as 
neurorehabilitation is a time of neurological growth and functional repair (Headway, 
2019), participants were highly likely to change throughout their research 
involvement. It is therefore possible that observed changes could relate to maturation 
rather than the intervention; however, the requirement for effects to be demonstrated 
for at least three participants across different baselines controlled for this.  
Another strength was the studies focus on the pursuit of goals throughout the 
intervention, rather than goal acheivement, as it is through this pursuit that 
meaningful behaviour occurs. Additionally, this reduced the possibility of self-
percieved failure, as suggested when supporting adjustment (Brands et al., 2012), and 
demonstrated that the pursuit of meaningful goals, whether or not acheieved, can lead 
to positive changes in valued living and mood. Such findings could influence service 
delivery as currently, due to service targets and comissioning, neurorehabilitation is 
heavily focused on goal attainment (Turner-Stokes, 2009). A final strength of the study 
was the flexible nature of the intervention, which allowed goals to be tailored to each 
participants cognitive and physical abilities; thus, encouraging meaningful living 
despite the consequences of their injuries. 
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Limitations of the study include the fact that only four individuals completed 
the baseline and intervention phases, with with only three individuals completing 
follow-up despite the study being powered for five participants. Additonally, VAS data 
did not consistently reach the desired MBD power (0.8) as 18 timepoints per phase 
were not attained. This was due to COVID-19 restrictions (e.g., no crossing of wards) 
making it difficult to collect measures for some participants and an increasing reliance 
on external support (e.g. carers) to assist with VAS collection. Study findings are 
therefore tentative and further research is needed to confirm outcomes.    
Furthermore, two of the four participants (Pt2, Pt4) were taking psychotropic 
medication for low mood during their research involvement, with Pt2 also engaging in 
psychological therapy for anxiety, which overlapped with the final session of the 
research intervention. Although such factors could influence findings, discussions with 
the hospital medical and psychology teams allowed for careful monitoring of both 
pharmacological treatment and additional therapeutic input. This ensured that the 
stability of medication effects could be evaluated throughout the study, and prevented 
any overlap of the values-based approach between psychological therapies.   
A further study limitation is the sole use of self-report measures. Despite 
researchers recommending their use when assessing self-percieved concepts such as 
mood, adjustment and quality of life (Ditchman et al., 2019; Verdugo et al., 2019, von 
Steinbuechel et al., 2016), it is possible that findings do not accurately reflect 
participant experience. For instance, due to a social-desirability bias, participants may 
have responded to measures based on what they believed the therapist was hoping for 
(Rosenma, Tennekoon & Hill, 2011). This could have led to an underreporting of 
symptoms, in attempt to portray themselves as coping well with their injury following 
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the intervention. Alternatively, participants may have overreported symptoms in effort 
to gain support from the researcher. It is therefore recommended that future studies 
reduce the potential for bias by including an independent assessor to administer 
outcome measures, and increase the reliability of findings by including caregiver rated 
measures alongside self-report (e.g., from staff members) (Barlow, Nock & Hersen, 
2008). Unfortunately, neither recommendation was possible in the present study due 
to understaffing and restrictions around new staff entering the hospital during 
COVID-19.  
Additional limitations arise when examining the outcome measures used in the 
study. For instance, although the HADS-D is validated within ABI populations 
(Schönberger & Ponsford, 2010; Aben et al., 2002), certain items are arguably 
unsuitable for this group. Items measuring whether participants still enjoyed the things 
they ‘used to enjoy’ may relate more to being in a hospital environment, particularly 
during COVID-19 when participants were severely restricted and often unable to 
access previously enjoyed activities. Additionally, items that focus on how ‘slowed 
down’ participants were may have captured the effects of their physical impairments 
post-injury (Goldstein, Atkins & Leigh, 2002) rather than symptoms of depression. 
Furthermore, as there are no existing benchmarks for HADS-D scores during 
neurorehabilitation, it is difficult to assess whether changes on the measure go beyond 
what would be usual and expected for this group. Similarly, despite the QOLIBRI 
being a brain injury specific measure, it may omit specific life domains that hold 
personal significance to individuals (Fernandez et al., 2019). It is therefore possible 
that standardised measures failed to truly capture individual circumstances and 
experiences; hence, the idiosyncratic VAS measures partially controlled for this.  
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Finally, the two-week planned follow-up period is relatively short, particularly 
since previous studies have outlined delayed treatment effects of up to six months in 
ABI groups (Hsieh et al., 2012). A longer-term follow-up period would have provided 
further information around maintenance effects; however, this was not possible due to 
admission lengths and participant discharges. Further issues include the fact that two 
participants contracted COVID-19 around the time of their follow-up, meaning that 
Pt1’s follow-up took place one month after his final session, following his discharge, 
and Pt3’s final session and follow-up period took place after a three-month delay 
between her final two sessions. Hence, for both participants extraneous factors may 
have influenced follow-up measures (e.g., the aftereffects of being unwell and/or the 
fact that they were completed once in the home environment). Interestingly, following 
Pt1 up whilst in the community offered some insight into how values-based work can 
continue post-discharge, translating from the hospital to home environment when 
individuals are back to their usual routines and have their loved ones around them. 
Further exploration of values-based treatments following discharge is warranted, given 
that interventions aim to support individuals in living by their values as part of a 
lifelong process. Additionally, the imagery sections of the intervention are arguably 
more applicable when thinking about future events once at home rather than during 
rehabilitation. Participants reported that they were assisted and encouraged by staff to 
engage in identified valued activities on the ward, and thus, may benefit from 
strategies that increase motivation once home and in a less structured environment. 
Future Directions 
It would be helpful for future research to combat issues with measurement and 
self-report by also including observer-rated measures of mood and meaningful 
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behaviour. Observer-rated outcomes could be completed by those close to the 
participant, such as family or staff members. Furthermore, despite the use of 
standardised measures validated for ABI groups, issues with the applicability of 
measurements remained. Hence, it would be interesting to use clinical interviews with 
both the participant and caregivers to supplement standardised measures. Increased 
service user involvement would also be helpful in reviewing the chosen outcome 
measures and their applicability to ABI groups, in addition to reviewing the therapy 
protocol. Finally, future research could more closely examine the relationship between 
mood and valued-behaviour outcomes, which was inconsistent across participants in 
the present study and suggests that whilst increased valued-behaviour can improve 
mood, this is not always the case.  
 Moreover, in the present study, effects were not often maintained at follow-up; 
however several issues with follow-up periods arose (e.g., participant discharges or 
participants becoming unwell). Whilst such factors could not be prevented, including a 
consistent and longer follow-up period for all participants would be helpful in 
monitoring the effects of the intervention overtime. This may be more likely in 
community samples where discharge is less of a factor. Following individuals up in the 
community, or trialling the intervention within community ABI groups, would also 
inform how values-based approaches can be adapted to the home environment, better 
tailoring the intervention to an individuals life and supporting them to live by their 
values longterm. This is particularly interesting given the varied response to discharge 
between participants, and the adjustment issues highlighted by Pt1 once home (e.g., 
his realisation that he required increased support from his family), which negatively 
impacted on his mood. Furthermore, important decisions made once home (e.g., 
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whether or not an individual can return to employment) are likely to heavily influence 
mood and valued-behaviour, and may be supported by a values-based approach. 
 Lastly, whilst some sites have begun to incorporate values-based goal-setting 
into neurorehabilitation, this is rare. The present study demonstrated that focusing on 
an individuals values can support them in living more meaningful lives, despite the 
consequences of their injuries; hence, it is advised that professionals draw upon an 
individuals values when setting collaborative rehabilitation goals.  
Conclusions 
This study used a MBD to evaluate the use of a values-based intervention for 
neurorehabilitation inpatients with an ABI and symptoms of depression. The design 
enabled stringent analysis, whilst allowing for cases to be studied individually and in 
detail, which is appropriate given the heterogeneity of the ABI population. The 
flexible nature of the research intervention meant that participants physical and 
cognitive difficulties could be considered when establishing values-based goals, 
encouraging them to engage in meaningful behaviours despite the consequences of 
their ABI. All participants reported increased values-consistent behaviours across the 
course of therapy, with most engaging in self-directed values-based behaviours in 
addition the goals formulated in sessions. Three out of four participants improved on 
at least one variable, with the most improvement made in depression. However, as the 
study was underpowered clear conclusions cannot be drawn. Additionally, limitations 
including the sole use of self-report, and the uncontrollibility of the rehabilitation 


















Chapter IV: Integration, Impact and Dissemination 
This chapter aims to first provide a synthesis of the main two aspects of the 
thesis, the systematic review (SR) and the empirical study (ES). It will then discuss the 
 146 
potential academic and clinical impact of research findings, before reviewing how 
findings will likely be disseminated in the future. Reflections and critical appraisals of 
the project will be provided throughout.  
Integration 
This section discusses and reflects on the process of working on the two 
interrelated thesis components, focusing on the level of synergy achieved between 
them. When beginning the project my principal aim was to evaluate and advance the 
evidence-base for the use of psychological interventions for adults with an Acquired 
Brain Injury (ABI), which was achieved through the combination of the SR and ES. 
As recent reviews (e.g., Sharma, unpublished thesis) have examined the existing 
literature for Acceptance and Commitment Therapy (ACT) within the ABI 
population, the decision was made for the SR to instead review the available 
evidence-base for imagery use within psychological interventions in this group. Thus, 
relating to the proposed addition of imagery within the values-based therapy in the 
ES. However, as outlined below, whilst the SR influenced the study design, intended 
recruitment and service user involvement, the use of imagery was not indicated for the 
recruited ES participants, meaning that the relationship between the two components 
is less clear. 
Conceptual Basis 
The SR explored the effectiveness of imagery-based interventions on 
psychological outcomes after an ABI. It aimed to cover the common causes and 
consequences of an ABI, summarise the most heavily utilised psychological 
interventions to date, and develop the reader’s understanding of mental imagery as a 
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method of improving cognitive function, mood and/or behaviour post-injury. It 
outlined that mental imagery aims to simulate or recreate perceptual experience in the 
absence of corresponding stimuli (Pearson et al., 2013), highlighting that imagery 
functions similarly to sensory perception (Pearson et al., 2015; Tartaglia et al., 2009) 
and can generalise from the imagined to the perceptual content (e.g., Lewis, O’Reilly, 
Khuu & Pearson, 2013). The SR demonstrated how, in non-ABI groups, imagery has 
been shown to enhance cognitive functions including perceptual learning (Tartaglia et 
al., 2009), memory, and executive functioning (e.g., planning and decision making; 
Pearson et al., 2015), and emphasised the key role of imagery in the development and 
maintenance of numerous psychological disorders, thus, highlighting how it has also 
informed the available clinical treatments. Additionally, the SR demonstrated how 
imagery has effectively impacted motivation across a range of maladaptive behaviours 
outside of the ABI population (e.g., May et al., 2015; Renner et al., 2019). However, 
whilst the consequences of ABI often correspond to these three areas (i.e., cognition, 
mood, and behaviour), I was surprised to find limited numbers of studies specifically 
exploring imagery use in this group, with research especially sparse outside of the 
cognitive domain.  
 Still, the SR provided an understanding of the theoretical underpinnings of 
mental imagery. The reviewed studies, using imagery within ABI groups, were 
instrumental in the development of the imagery component of the ES intervention. 
For instance, researchers reported incorporating detailed sensory information and a 
high level of repetition within imagery exercises, which was replicated in the imagery 
component of the ES. However, despite the ES planning to use imagery to increase 
motivation for values-consistent behaviours, this was not indicated. Participants in the 
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ES exhibited high levels of motivation and positive biases in future thinking, despite 
experiencing symptoms of depression. They reported that the encouragement from 
staff and structured hospital environment helped motivate them to engage with their 
values-based goals. I therefore wonder whether techniques to support motivation 
would be more applicable outside of this context (e.g., once discharged); thus, the use 
of imagery may be more useful in community ABI samples.  
Nonetheless, aside from the imagery component, both the SR and ES required 
a thorough understanding of ABI and its consequences. Thankfully, whilst writing 
these sections, I undertook a six-month placement in neurorehabilitation, which took 
place at the ES recruitment site. Through both in-house training and working with a 
large caseload of patients with differing ABI aetiologies, I was able to integrate the two 
thesis components, enhancing both my theoretical and clinical knowledge of brain 
injury.  
Design 
The SR highlighted a number of limitations in previous ABI research, with the 
reviewed papers often including small sample sizes in addition to a lack of control 
groups. As recommended by some of the reviewed studies, the ES adopted a high-
quality Single Case Experimental Design (SCED). Due to the level of control provided 
by randomisation and the strict criteria for causality to be established in SCED (i.e., 
effects needed to be demonstrated for at least three participants across different 
baselines; Horner et al, 2005; Kratchowill et al., 2010), a smaller sample size was 
appropriate. Additionally, considering the heterogeneity of ABI samples, and the 
diversity seen across participants in the ES (e.g., participants were at different stages of 
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their rehabilitation journey and were experiencing different symptoms post-injury) the 
use of a SCED appeared most fitting, allowing for data to be analysed individually 
and in detail, with participants acting as their own control. This is contrary to other 
controlled designs such as Randomised Control Trials (RCT), which recruit larger 
samples and analyse group data, thus, providing less detailed information around 
treatment response on an individual level.  
Recruitment  
Previous research, detailed in the SR, outlined a number of study limitations 
including the fact that studies were often underpowered due to small sample sizes. 
The ES attempted to overcome this, proposing a sample size of six. Sample size was 
predominantly determined by establishing power based on the design requirements 
(Shadish et al., 2014) and by reviewing previous SCEDs also conducted within ABI 
groups (e.g., Sharma, in prep). Unfortunately, the desired recruitment was not 
achieved due to COVID-19 restrictions heavily impacting on recruitment. 
Restrictions included the fact that one of the two recruitment sites paused all non-
covid related research, meaning that it was not possible to recruit at all from this site. 
Additionally, the remaining recruitment site was divided into ‘zones’, which could not 
be crossed. For the majority of the recruitment period, this limited recruitment to just 
one ward, on which participants were admitted for approximately 12 weeks. Hence, 
new admissions were relatively infrequent and limited numbers of patients could be 
assessed for study eligibility. Two participants were recruited from a second ward 
during periods of eased restrictions; however, when restrictions were reintroduced, 
sessions were required to switch to videocall for one of these participants. The idea of 
virtual sessions was explored further in attempt to recruit additional participants; 
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however, this was not a feasible alternative due to the increased presence of 
communication and cognitive impairments in the ABI population. In addition to these 
restrictions, two participants who consented to the study were withdrawn during their 
research involvement. This was due to one participant contracting COVID-19 and 
being discharged early during his baseline period, and the second participant 
experiencing an increase in risk (i.e., increased suicidal thoughts and intent) following 
a separation from their partner mid-way through the intervention. Whilst this increase 
in risk was not considered to relate to the research therapy, it was deemed 
inappropriate to continue with sessions due to the novelty of the treatment. Instead, 
the participant was treated as per normal practice by the hospital psychology team. As 
a consequence, four participants completed the intervention, with one individual lost 
to follow due to an early discharge and moving countries. Hence, findings of the ES 
are tentative and further research with larger sample sizes is required. 
In contrast to the ES, which solely recruited participants undergoing a period 
of inpatient neurorehabilitation, only one of the nine studies reviewed in the SR 
reported recruiting participants from inpatient wards. Due to differences in the two 
settings, this may have affected participant response to treatment. However, the 
decision to recruit for the ES from inpatient settings was made due to the wider 
literature, which argues that the principles of ACT fit well within neurorehabilitation 
when individuals are supported to rebuild a meaningful life by working towards 
personalised therapeutic goals (Kangas & McDonald, 2011; Soo et al., 2011; Turner-
Stokes et al., 2005). Moreover, neurorehabilitation represents a critical time in an 
individual’s recovery journey and intervening at this stage is likely to aid adjustment 
and increase the impact of rehabilitation long term. Nonetheless, I propose that future 
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research evaluates the use of values-based approaches within community ABI groups. 
I suggest this due not only to the SR, which outlined ongoing difficulties for 
individuals in the community, but also in consideration of the ES, in which 
participants were shown to have a complex and idiosyncratic response to discharge 
and community reintegration that may be supported by a values-based approach.  
  In terms of participant characteristics, the studies synthesised in the SR 
predominantly recruited individuals who had experienced a Traumatic Brain Injury 
(TBI) following a Road Traffic Accident (RTA) or a fall, despite inclusion criteria 
encompassing all non-progressive ABIs (e.g., injuries caused by anoxic or hypoxic 
events and infection-related diseases such as encephalitis, septicaemia, or meningitis). 
Moreover, a male predominance was found across the reviewed studies. This is 
reflective of national statistics, which outline a male predominance in cases of TBI in 
the UK (Anke et al., 2015; Numminen et al., 2011; Perez et al., 2012) usually resulting 
from falls or RTAs (Peeters et al., 2015). Surprisingly, in the ES, none of the 
participants experienced a TBI. Instead, participants experienced injuries 
predominantly caused by a stroke, anoxic or hypoxic events. Additionally, half of the 
participants in the ES were female, again at odds with the SR and wider literature. 
Differences between the ES and wider literature (including the SR) are most likely due 
to the small sample size in the study, which decreases the generalisability of results. 
Generalisability could have been increased by recruiting across a number of wards 
and hospital sites; however, as outlined above, this was not feasible in the context of 
COVID-19.  
Due to the ES being underpowered, the study is continuing (with a new 
researcher) to provide further clarity around the usefulness of the values-based 
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intervention in ABI groups with depression. It is therefore helpful to reflect not only 
on the challenges faced, but also on what assisted with the recruitment and retention 
of four individuals despite the difficult circumstances discussed above. Firstly, I found 
that being on placement at the recruitment site was incredibly beneficial in 
establishing a presence within the wider psychology and multidisciplinary teams. This 
meant that I could speak regularly with the team about clients, staying mindful of the 
wider rehabilitation context. Additionally, other team members could be kept 
informed about the study, and thus, were able to assist participants in engaging with 
their values-based goals established during therapy. Secondly, being on site meant 
that I could hold the eligibility criteria in mind whilst assessing new admissions. 
Finally, prior to recruitment, I was able to present the study (background, design, and 
inclusion criteria) to the wider psychology team, following up with an information 
pack that outlined this information. At the time, this resulted in a number of referrals 
from wards around the hospital. Unfortunately, the introduction of new COVID-19 
restrictions shortly afterwards prevented some of these individuals from partaking in 
the study. 
Service User Involvement 
When reflecting on the level of service user (SU) involvement across the SR 
and ES, I first consulted the ‘ladder of participation’ (Arnstein, 1969). This describes 
SU input as ranging from ‘no control’, whereby SU’s are considered ‘passive 
consumers’ with no influence over the service that they receive, to ‘full control’ 
whereby SU’s make service-related decisions at the highest level. As demonstrated 
below, SU involvement in the ES falls on the ‘participation step’ (the fourth step out of 
six) as SU’s were able to make suggestions and influence outcomes.  
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SU feedback was particularly valuable in the development of study documents 
including the Participant Information Sheet (PIS; Appendix 3) and the Participant 
Consent Form (PCF; Appendix 4). These were drafted by Sharma (in prep) before two 
SU’s at the recruitment site provided feedback on the content, wording, and style of 
the drafts. Additionally, SU’s at the recruitment site were consulted about homework 
tasks likely to be set between sessions, and the daily VAS measures that were 
completed throughout the study. They were able to offer suggestions on how 
participants may be supported when completing these tasks, in consideration of their 
cognitive and physical abilities. In line with SU suggestions, the PIS and PCF were 
edited, and processes were put in place to offer participants support in completing the 
VAS measures (e.g., email reminders were sent, virtual copies of the measures were 
created, and staff or caregivers were contacted to ensure that participants could be 
assisted practically with measure completion).  
In terms of the intervention, previous literature recommendations (e.g., 
Kangas & McDonald, 2011; Soo et al., 2011), including those highlighted by SR 
studies (e.g., Campbell et al., 2019; O’Neill & McMillan, 2012), were implemented to 
ensure applicability to ABI groups. For instance, participants were provided with 
easy-to-read handouts and summary sheets, and the therapist utilised simplified 
explanations, repetition, concrete examples, and metaphors to portray more complex 
concepts. Finally, each participant was consulted about how best study results may be 
communicated (see dissemination section below). 
In terms of the SR, SU input fell on the ‘no control’ step of the ladder. 
Therefore, one way to increase SU involvement would have been to discuss possible 
review questions with SU groups. Additionally, only two individuals were approached 
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to offer feedback on elements of the ES, thus, the suggestions made may not be 
generalisable to the wider ABI population. Consulting higher numbers of SU’s would 
have therefore been valuable. SU’s could have also been approached prior to the 
development of study documents to ensure participation from the onset. Finally, in 
addition to consulting the relevant literature, gathering SU opinions on the 
intervention itself would have been useful, ensuring that the materials used were 
presented in a clear and accessible manner. Encouraging further SU involvement in 
this way would not only enhance the quality of study resources but would also 
empower the individuals approached. 
Summary  
Overall, there is some integration between SR and ES, with both components 
aiming to improve services for adults with an ABI. Both sections also inform the 
reader of the consequences of ABI and, when combined, offer critical appraisals on 
the most heavily researched psychological interventions in this group to date. The ES 
drew upon the wider literature, including papers referenced in SR, to identify 
downfalls in study design and to develop a higher quality study appropriate in the 
heterogeneous ABI population. Nonetheless, the lack of imagery use in the ES limits 
the level of synergy achieved between the two components. 
Impact 
The study outlined positive clinical implications for individuals with an ABI 
and depression following a values-based intervention. Participants were supported to 
engage in increased values-consistent behaviours across the course of therapy, whilst 
taking their individual desires, needs and abilities into account. This was 
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demonstrated through self-report measures in addition to informal qualitative 
feedback from participants and staff. What’s more, three out of four participants 
reported a reduction in symptoms of depression on standardised outcomes, with half 
of participants also reporting heightened levels of adjustment immediately post-
intervention. With up to 40% of mild to moderate ABI patients experiencing clinical 
levels of anxiety and/or depression (Seel & Kreutzer, 2003; Wellisch, Kaleita, 
Freeman, Cloughesy, & Goldman, 2002), such findings could have a substantial 
clinical impact in the future. The intervention exhibited less influence on quality-of-
life (QoL) measures, with three participants demonstrating no reliable changes in QoL 
following the intervention and one individual reliably deteriorating in the QoL self-
perception subscale at follow-up (a deterioration that was not present immediately 
post-intervention). Nonetheless, findings are comparable to previous research, in both 
ABI (Sharma, in prep) and non-ABI groups (Villatte et al., 2016), which has 
demonstrated that drawing upon individual ACT components can be as impactful for 
individuals as using ACT in its entirety. Additionally, both Villate et al. and Sharma 
highlighted how QoL does not always improve alongside symptom reduction, and 
vice versa. 
 Despite previous research beginning to explore a modularised approach to 
ACT, to my knowledge this is the first study to examine the impact of the ‘behavioural 
components’ (i.e., values and committed action) with individuals post-ABI who also 
score above clinical threshold for depression. The study confirmed that the values-
based approach can be effectively delivered across an average of six 45-minute 
sessions in this group, with the intervention found to be accessible and acceptable by 
all participants. This is evidenced by formal feedback on a survey assessing client 
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satisfaction in addition to the fact that no sessions were declined. It is supported by the 
wider literature, with Soo et al. (2011) suggesting that using only the behavioural 
component of ACT reduces the cognitive demand placed on individuals and arguing 
that the cognitive components of ACT (e.g., cognitive defusion) are less suitable for 
ABI groups due to the presence of cognitive impairments. 
 Notably, the conclusions drawn by the study are tentative due mostly to the 
small sample size and the study being underpowered. Further research is therefore 
planned in order to provide additional information around treatment response in this 
group. As the evidence-base for a standalone values-based therapy increases, it would 
be beneficial to routinely offer this to patients undergoing neurorehabilitation, 
particularly given the short-term nature of the intervention and the favourable 
outcomes achieved in this context thus far. Moreover, as neurorehabilitation is heavily 
focused on goal attainment, with rehabilitation goals frequently informing important 
decisions such as admission lengths and continued funding, the research intervention 
could inform goal setting procedures within this setting. That is, services could 
incorporate an individual’s values in their rehabilitation goals. In discussions with 
other inpatient services, a number of sites have expressed an interest in this, in 
addition to a desire to incorporate values-based work more broadly into everyday 
rehabilitation.  
 It is intended that the project will have further influence across a range of 
services, including community settings and the charitable sector. Given the promising 
findings for values-based approaches within inpatient neurorehabilitation, it is hoped 
that it will encourage further research to explore how the intervention can be utilised 
post-discharge. Focusing on an individual’s values at this time could help them to 
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reintegrate into the community, adjust to life outside of a hospital setting and make 
important decisions about their future (e.g., returning to employment, living 
circumstances, and so on). Dissemination is likely to support this aim, raising 
awareness of how services can better support individuals by holding their personal 
values in mind at all stages of the available treatment pathways. 
Carrying out this project positively impacted me on both a professional and 
personal level. Although conducting the therapy sessions was originally a daunting 
experience, I was well supported by my academic supervisor who provided invaluable 
guidance in applying the intervention in practice, strengthening my theory-practice 
links, and increasing my confidence in my clinical abilities. Working on placement at 
the recruitment site and managing the competing demands of my clinical work and 
research sessions was a challenging yet rewarding experience. Having direct 
involvement with patients meant that I witnessed first-hand the positive impact of 
focusing more on what was truly important and made the project feel extremely 
meaningful. This was particularly true in the context of COVID-19 when many 
individuals were severely restricted and unable to access these things in the way they 
would have previously. Overall, this project has informed my practice in a wider 
sense. I have begun to incorporate patients’ values into my formulations, advocating 
for an individual’s values to be considered in treatment planning, team meetings and 
joint sessions with other health professionals. I will continue to use values-informed 
philosophies in my work going forward, evidenced by a recent values-based group I 
developed, under supervision, for caregivers of individuals with learning disabilities. 
Keeping a client’s personal values in mind has helped me to ensure that my practice 




In order to disseminate the thesis findings to the research community, the ES is 
due to be presented at the Association for Contextual Behavioural Science (ACBS) 
world conference in June 2021. Presentation at further relevant conferences such as 
the British Psychological Society (BPS) Division of Neuropsychology Annual 
Conference may also be possible. In addition to this, I hope to submit findings to a 
wider audience through publication in peer-reviewed journals. Possible journals 
include:  
o The Archives of Clinical Neuropsychology 
o Neuropsychological Rehabilitation; An International Journal  
o The Neuropsychologist (The British Psychological Society) 
o Behaviour Research and Therapy  
o The Journal of Contextual Behavioural Science 
Clinical Community 
Aside from conference presentations and journal publication, clinicians at the 
recruitment site will be provided with a summary of the research findings and their 
key clinical implications. This will be offered in the form of a poster that can be 
distributed to the wider team, as well as a presentation that can be delivered to the 
psychology team during their weekly team meeting. From my discussions with various 
team members, the key areas of interest were: (1) the importance of incorporating a 
client’s values into their neurorehabilitation goals, embedding them into the goal-
setting procedures within the hospital. This is especially important as currently goals 
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are often primarily informed by commissioning requirements, clinical opinions, and 
staff expertise; (2) the suitability of SCED within ABI. This allows researchers to 
gather an in depth understanding about treatment response in heterogenous 
populations whilst maintaining increased experimental control; (3) the challenges 
faced when conducting research within neurorehabilitation; and (4) how this project 
may be progressed, for example, by examining the impact of the intervention in 
community settings or with caregivers of individuals with an ABI.  
Service Users  
All participants have been offered a summary of their research findings and expressed 
an interest in receiving this. Results will be presented to participants at a level 
appropriate to their cognitive abilities. Discussions with each individual informed me 
on how best I can achieve this, with suggestions including the use of visual 
representations of data (e.g., graphs), simplified language, less detailed statistical 
information, and the inclusion of the practical implications of findings. The lay 
summary (see Chapter 1) can also be disseminated more widely, for instance in 
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Appendix 4: Participant consent form. 
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Appendix 5: Visual Analogue Scales (VAS) used for all participants.  
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Appendix 9: Bullseye Values Survey (BEVS; Lundgren, Luoma, Dahl, Strosahl & Melin, 2012).
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Appendix 10: Client Satisfaction Questionnaire (CSQ; Larsen, Attkisson, Hargreaves 
& Nguyen, 1979). 
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Appendix 12: TAU-U Analysis for Participants VAS Data Across Phases. 
 
Table 12 
  Low Mood Meaningful Living 
Pt Comparison Tau SD Tau p-value 90% CI Tau SD Tau p-value 90% CI 
1 A x B 
B x FU 

























2 A x B 
B x FU 

























3 A x B 
B x FU 

























4 A x B .24 .25 .34 -0.172<>0.646 .53 .25 .03* 0.125<>0.942 
 230 
 
Note. Pt=Participant; A=Baseline phase; B=Intervention phase; FU=Follow-up phase; SD=Standard deviation; CI=Confidence Interval; * = 
p<.05; ** = p<.01; ~ = baseline trend corrected
 231 
Appendix 13: Raw Scores for Standardised Measures (HADS-D, QOLIBRI, RIDI). 
 
Table 13 













































































RIDI 12 14 12 - 
Note. Desired direction of change: decrease in HADS-D scores, and an increase in 
QOLIBRI and RIDI scores. QOLIBRI transformed scores are used ranging from 0-
100. 
